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ABSTRACT
Crustacean processing in Louisiana generates vast amounts of byproducts, including
crawfish processing byproducts (CB), whose disposal can be problematic unless utilized
alternatively. The objective of this investigation was to design and develop a delivery system
(DS) containing extracted astaxanthin (AX) from CB using a novel combined ethanol flaxseed
oil (FO) ultrasound assisted extraction (UAE) method and evaluate its quality characteristics.
Additionally, anticancer effects of AX were evaluated. Investigations consisted of three studies.
Proximate composition, oxidative stability, and antioxidant capacity of AX from CB
extracted both conventionally and by UAE was determined. AX concentration conventionally
extracted from CB (FOCAX) was 0.0919 mg g−1 of FO. The combined UAE ethanol FO
extracted AX from CB (FOCAXUAE) was 1.9 mg g−1 of FO with antioxidant capacity
(71.81±0.42) significantly greater than FOCAX (63.16±0.22). FOCAXUAE was selected for use
in further studies.
A pectin gelatin DSs (PGDS) for controlled release of extracted AX was developed.
Releasing profiles of several formulations containing high degrees of methylation (HMP) or low
degrees of methylation (LMP) pectins were evaluated. The in vitro release study investigated
release of AX in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF). However,
desired release characteristics were obtained with the addition of hydroxypropyl methylcellulose
(HPMC). Swelling index of both HMP and LMP formulations with HPMC in SIF after 180
minutes were 126.46% and 90.61%, respectively. Other formulations failed to swell in SIF, with
exposure to low pH SGF resulting in all formulations rapidly releasing FOCAXUAE.
Anticancer properties were considered. A control (sunflower lecithin and FO in DMEM,
Dulbecco’s modified Eagles medium) in the ratio (0.0025:0.005:1) on the viability of MDA-MB-

xv

231 cell lines showed RCV (relative cell viability) of 79.37±0.87 % (RCV of 97.37±0.06%,
normalized to DMEM alone). RCV of MDA-MB-231 cells treated with AX (3µM, 5µM, and 7
µM) had significantly decreased (46.31±0.81%, 42.2±0.65%, and 55.51±0.19%, respectively).
Cell densities decreased in some groups treated with AX, showing fewer cells with
mesenchymal-like shapes, suggesting reversal of the epithelial-to-mesenchymal transition
(EMT). This research indicates high amounts of AX extracted from CB by UAE has cytotoxic
activity that could be incorporated into polymer-based DS.

xvi

CHAPTER 1
1.1

LITERATURE REVIEW

Louisiana seafood
The State of Louisiana is known as the “Sportsman’s Paradise” due to its beautiful landscape

for hunting and waters for fishing, that attract tourist from around the world. In addition to the
thrill or hunting and fishing, there are a plethora of restaurants throughout Louisiana that serve
up that delicious food that many people long to experience. From an economic standpoint,
Louisiana seafood industry generates almost $2 billion in sales annually, while supporting over
33,000 jobs, not including recreational fishing (Gaudé, 2019).
1.1.1

Red swamp crawfish (Procambarus clarkii)
In 1983 the red swamp crawfish (Procambarus clarkii) Louisiana crawfish, was

designated as the state's crustacean (Schedler, 2011). In North America, Louisiana dominates the
crawfish industry, accounting for about 90%-95% of the total production in the United States.
Crawfish are an important commercial species cultured with high market values exceeding $170
million annually (Osti, Bampasidou, & Fannin, 2018). In the southern region of the United States
crawfish are regarded more communally and have had a greater impact economically than any
other place where they exist in the world. In addition to the edible portions of crawfish, several
other components can be derived from crawfish byproducts like flavor compounds, chitin,
chitosan and carotenoids like astaxanthin (Meyers & Bligh, 1981; Hong K No & Meyers, 1989;
Hong K No, Meyers, & Lee, 1989; Tanchotikul & Hsieh, 1989).
Even with the high market value associated with crawfish they are much appreciated in
many states across the United States. The market value of Louisiana crawfish exceeds more than
$170 million annually, reportedly adding $300 million to the state’s economy (Johnson, 2019).
Crawfish are frequently sold boiled ready to eat, live in sacks for crawfish boils, or as frozen
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peeled tail-meat. In times of oversupply, large crawfish remain in the live market and sometimes
smaller crawfish are produced for meat (Editor, 2010). These undersized, also termed
underutilized crawfish, have very little market value and are often discarded. Subsequently, this
has resulted in an increase in the production of crawfish waste, or byproducts from processing.
The utilization of undersized crawfish or the shells from peeling operations for the extraction of
astaxanthin may increase the economic value of crawfish.
The Louisiana crawfish culture industry has been reported to be the largest crustacean
farming operation in the United States for more than 30 years. Much, if not most, of the crawfish
production is consumed and or processed in the state within two relatively concentrated areas,
Breaux Bridge, LA and Crowley, LA (Laudun, 2016; Mulcahy, Naquin, & Harper, 2019; Poudel,
2016; Richardson, 2015). Therefore, there should be a stable supply of byproducts for conversion
into alternative products. There is a great potential in the crawfish processing industry to convert
previously discarded byproducts into valuable products. Please note that the term byproducts is
not clearly defined to distinguish it from waste and it is often identified as leftovers that are not
ordinarily saleable, rather than potentially valuable components that can be used with proper
treatment.
1.2 Antioxidants
The prevention of diseases is important to health and well-being. People are encouraged
to eat a well-balanced diet and to exercise, in efforts to avoid illness. Antioxidants are reported to
play a noteworthy role in both the prevention and treatment of diseases. Antioxidants are
naturally found in fruits and vegetables or can be additives used to preserve food from “farm to
table”, that prevent deterioration in storage and processing (Griffiths et al., 2016). Antioxidants
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may also be present in health and beauty products like face creams and shampoo. They function
to combat oxidation of compounds in products that result in the loss of functional quality.
All biological systems exist in redox equilibrium, balancing reducing and oxidative
reactions to meet necessary conditions for life (Gaschler & Stockwell, 2017). An imbalance of
the aforementioned redox equilibrium results in potentially severe biological damage. In the case
of aerobic organisms, oxidation is a normal metabolic process in which energy is produced
through a series of reactions that involve oxidants. When there is an overproduction of ROS,
such as the superoxide anion radical (%"& ), hydrogen peroxide ('" %" ), and the hydroxyl radical
(HO*) or reactive nitrogen species (RNS), the biological redox balance called redox equilibrium
is tilted, creating oxidative stress (Figure 1.1). Antioxidants function to combat oxidative stress
in the body. These include non-enzymatic scavengers such as vitamin C and E, glutathione
(GSH), lipoic acid, carotenoids and iron chelators, as well as enzymatic scavengers such as
superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx) and peroxiredoxins (RedzaDutordoir & Averill-Bates, 2016). Conversely, an overproduction of reductants leads to
reductive stress (Woods, Wilund, Martin, & Kistler, 2012).
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Biological Redox Balance
A delicate balance between oxidizing compounds and reductants
Antioxidants

Reactive Oxygen Species

Oxidative Stress
Balanced

Reductive Stress
Figure 1.1. Balance
of redox
equilibrium.
Source:ofSpickett,
Fedorova,
Hoffmann, and Forman
Imbalance
when
production
defenses
is unfavored
(2015)
The beneficial effects of natural antioxidants found in fruits and vegetables are related to
three major groups: carotenoids, phenolics, and vitamins. Of the three categories, carotenoids are
known as lipophilic antioxidants, with the others being hydrophilic (Thaipong, Boonprakob,
Crosby, Cisneros-Zevallos, & Hawkins Byrne, 2006). Antioxidants compounds may be produced
in the body or obtained from food or supplements, and may be either natural or man-made. As
mentioned earlier, antioxidants prevent foods from spoiling, Examples of natural antioxidants
include SOD and GPx, both produced by the body, and chemical antioxidants, such as the
carotenoids, vitamin E, lutein, and astaxanthin, all dietary. Antioxidants can prevent certain types
of cell damage or lipid oxidation induced by oxidative stress. They have also been used as
reactive oxygen species scavengers to eliminate oxidative stress.
Several carotenoids act as potent antioxidants. Antioxidants have various health benefits,
including prevention of ocular disease, reduction of inflammation, prevention of Alzheimer’s
disease, reduction of the risk of stroke, and the improvement of blood glucose in diabetic therapy
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(Bahonar, Saadatnia, Khorvash, Maracy, & Khosravi, 2017; Behl & Moosmann, 2002; C. Li et
al., 2017; N. Singh & Ghosh, 2019). Recently antioxidants were reported to reduce the incidence
of coronary heart disease and prevent cancers. A more detailed discussion follows.
1.2.1

Reduction of inflammation
Oxidative stress triggers the release of cell signaling proteins, chemokines, cytokines, and

activation of their receptors as well as lipid peroxidation in the human body. Resulting in the
generation of pro-inflammatory, which are not an indication of the abnormalities directly caused
by the disease but are due to the activation of the body’s defense mechanisms. However, this
self-defense mechanism, collectively termed inflammation, may become harmful if it transforms
into chronic inflammation (Levine, Mizushima, & Virgin, 2011). For example, Helicobacter
pylori, a Gram-negative bacterium, causes chronic gastritis. The pathogenesis is partly caused by
an immunological response and affects roughly half of the world population. Astaxanthin was
shown to attenuate gastritis caused by H. pylori infections by inhibiting the growth of the
bacterium, to ultimately suppress gastric inflammation (Bennedsen, Wang, Willén, Wadström, &
Andersen, 2000). Additionally, Kang and Kim (2017) found that the inflammatory response
impairment stimulated by H. pylori-infected gastric tissues is abated by astaxanthin modulating
the cellular response to shift the activation of T helper cell type 1 response towards T helper type
2 response.
1.2.2

Cancer prevention
Not only does the intake of dietary fats (i.e. saturated fats) promote the development of

coronary heart disease, they have also been linked to the development of certain cancers because
of the chemical changes they can undergo during thermal processing (Kolonel, 2001; Norat et
al., 2005). An approach to combat such deleterious effects has created much interest foods for
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cancer prevention, an interest in bioactive compounds, like antioxidants, from fruits and
vegetables has been promising. The importance of oxidative damage in the etiology of human
cancer and the need for intrinsic and dietary antioxidants was first studied by the American
biochemist, Dr. Bruce Ames. Most notably, Dr. Ames is known for the development of the Ames
test, which is an assay for mutagens and their potential to be carcinogenic. Researcher Totter
(1980) reported that oxygen radicals and lipid oxidation agents are contributors to DNA damage
that results in diseases like cancer. He also reported that tocopherol, a radical trap in lipid
membranes, was used in a variety of oxygen-related diseases and that it was capable of
ameliorating the damage and carcinogenicity of several quinones. In the same report, it was
mentioned that β -carotene in green and yellow vegetables in the diet may be anticarcinogens and
inhibits tumorigenesis is several cancer models in vivo (Shree et al., 2017; Totter, 1980). The
main carotenoid found in aquatic animals, microorganisms and seafood, astaxanthin has attracted
considerable attention in part due to it being more potent than that of β -carotene and other
carotenoids as it relates to its antitumoral activity (Palozza et al., 2009)
Several epidemiological studies indicate an association between nutritional habits and
prevention of several types of cancer (Campbell, Newton, Jacobs, Pollak, & Gapstur, 2019;
Emenaker & Vargas, 2018; Susan T Mayne, Playdon, & Rock, 2016). The relationship between
nutrition and cancer dates back before the 1940s, when researchers first considered that
restricting diet, namely a caloric restriction, resulted in delayed growth and development of
mouse carcinomas (Bischoff & Long, 1938; Sugiura & Benedict, 1936; Tannenbaum, 1940).
Nowadays, with the advancements in the fields of molecular biology, medicine, nutrition and
technology since the mid 20th century, researchers have turned the focus from not only caloric
restriction but to the restriction of foods thought to promote cancer and foods that contain cancer
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preventing components (antioxidant micronutrients).
1.3 Xanthophyll carotenoid: astaxanthin
Carotenoids, are non-polar, fat-soluble tetraterpenes consisting of linked isoprene units
found in nature and responsible for imparting color to pigments of many fish and shellfish
(Lindshield, 2012; Martínez-Delgado, Khandual, & Villanueva–Rodríguez, 2017; N. M.
Sachindra, Bhaskar, & Mahendrakar, 2005). Carotenoids are classified in two ways, whether or
not it is capable of being converted to Vitamin A, and on structural differences and polarity. The
oxygenated carotenoids are known as xanthophylls, whereas hydrocarbon carotenoids are known
as carotenes (Lindshield, 2012).
Natural pigments are found widespread in all living matter including mammals, fungi,
invertebrates, and marine algae (Delgado-Vargas, Jiménez, & Paredes-López, 2000). The
carotenoid family consists of more than 700 pigments synthesized de novo in higher plants,
mosses, algae, bacteria, and fungi whose structures are derived from the acyclic isoprenoid
lycopene (I. Higuera-Ciapara, Felix-Valenzuela, & Goycoolea, 2006; Jackson, Braun, & Ernst,
2008; Khachik, Beecher, & Smith Jr, 1995). There are two important classifications of
carotenoids; carotenes, a subclass composed of only hydrocarbons, and xanthophylls, a subclass
consisting of oxygenated derivatives of carotenes (Jackson et al., 2008).
Several carotenoids act as potent antioxidants in humans and have been investigated
because of their ability to lessen the damaging effects of ROS. A carotenoids ability to efficiently
scavenge free radicals and to absorb light in the visible region is due to the multiple conjugated
double bonds contained within its structure (Lindshield, 2012). Plants employ carotenoids light
harvesting ability in the complex that captures light for photosynthesis. Carotenoids are also
found in bacteria, yeasts, molds crustaceans and bird feathers. Mammals do not synthesize
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carotenoids; therefore, they must be obtained through diet.
Additionally, seafood can also be a source of marine natural pigments (Ferraro et al.,
2010). Chlorophylls, carotenoids and phycobiliproteins are three basic classes of natural
pigments found in seafood (Noomhorm, Ahmad, & Anal, 2014). Crawfish and shrimp
byproducts, contain high levels of health benefitting bioactive compounds, such as proteins,
carotenoids, minerals, pigments and flavor compounds (Ibrahim, Salama, & El-Banna, 1999).
Astaxanthin, a xanthophyll carotenoid synthesized by plants and algae and found in crustaceans,
is a well-known antioxidant with multiple health promoting qualities has gained much attention
recently (Ambati, Phang, Ravi, & Aswathanarayana, 2014).
Due to its outstanding antioxidant activity, astaxanthin is capable of providing protection
against cardiovascular diseases, different types of cancer, some diseases of the immunological
system, macular degeneration and age-related cataracts, the latter two being related to lightinduced oxidative processes in the eye (Guerin, Huntley, & Olaizola, 2003; I. Higuera-Ciapara et
al., 2006). Some research has shown the ability of astaxanthin to ameliorate triglycerides (TG)
and high-density lipoproteins (HDL) in animal studies, thus potentially improving lipid profiles
in humans (H. Yoshida et al., 2010). Additionally, the structure of astaxanthin makes it a more
potent anti-oxidant than β-carotene (Jackson et al., 2008).
Albeit astaxanthin having the capability of exerting antioxidant effects, it does so without
being a pro-oxidant. Pro-oxidants induce oxidative stress by hindering antioxidant systems or
generating reactive oxygen species. It is known that reactive oxygen species are the underlying
cause of many diseases and illnesses.
1.3.1

Chemical Structure
The carotenoid family consists of more than 700 pigments synthesized de novo in higher
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plants, mosses, algae, bacteria, and fungi divided into two groups, whose structures are derived
from the acyclic isoprenoid lycopene, seen in Figure 1.2 (I. Higuera-Ciapara et al., 2006; Jackson
et al., 2008). The two groups are based on the chemical elements they contain in their molecules:
carotenes, which are composed of only hydrocarbons, and xanthophylls, consisting of
oxygenated derivatives of carotenes (Jackson et al., 2008). The oxygen present in xanthophylls
may be present as hydroxyl (OH) groups, carbonyl (C=O) groups or as a combination of both.
Astaxanthin, a xanthophyll carotenoid, which is synthesized by plants and algae from lycopene
by oxidative functionalization, has strong antioxidant properties (Ambati et al., 2014). The
presence of OH and C=O in each ionone ring contribute to the strong antioxidant capacity of
astaxanthin and its ability to be esterified.

Figure 1.2. Carotenoid biosynthesis from lycopene. Source: Jackson et al. (2008).
Astaxanthin (3,3′-dihydroxy-β, β-carotene-4,4′-dione) is carotenoid pigment containing
11 conjugated double bonds and two hydroxyl groups, Figure 1.3 (Martínez-Delgado et al.,
2017). The long chain of conjugated double bonds (polyene) and two terminal ring systems
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(ionone rings) determine its chemical characteristics and light absorption properties of
astaxanthin. In nature, astaxanthin is found in three trans isomer, however the 3S, 3S’, seen in
Figure 1.4, is the most common (Coral-Hinostroza, Ytrestøyl, Ruyter, & Bjerkeng, 2004; I.
Higuera-Ciapara et al., 2006). Due to the different chirality at C-3, 3′, astaxanthin has three R/S
(optical) isomers including two enantiomers (3S,3′S) and (3R,3′R) and the meso form (3R,3′S)
(Figure 1.4).

Figure 1.3. Chemical structure of astaxanthin. Source: Lorenz and Cysewski (2000)

Figure 1.4. Structures of optical isomers all-E-astaxanthin. Source: Coral-Hinostroza et al.
(2004)
10

All-E configuration (a, straight chained) and the three Z configurations (b, c, and e, bent
chains) in Figure 1.5 below, have greater solubility and improved oral bioavailability (Østerlie,
Bjerkeng, & Liaaen-Jensen, 2000).

Figure 1.5. Geometrical isomers all-E-, 9Z-, 13Z- and 15Z-astaxanthin. Source: Østerlie,
Bjerkeng, and Liaaen-Jensen (1999)
1.3.2

Sources of Astaxanthin

1.3.2.1 Microorganisms
The primary source of the carotenoid astaxanthin present in aquatic animals is algae,
namely Haematococcus pluvialis, the most abundant source of natural astaxanthin (Guerin et al.,
2003; Maoka, 2011; Matsuno, 2001). Astaxanthin, a red fat-soluble xanthophyll carotenoid, can
be found in various microorganism (Table 1.1) including yeast, algae, bacteria (Asker, Beppu, &
Ueda, 2007; J. H. Lee, Kim, Choi, Lee, & Kim, 2004; Lemoine & Schoefs, 2010; Libkind,
Moliné, de García, Fontenla, & van Broock, 2008). Commercial astaxanthin is mainly from
Phaffia yeast, Haematococcus and through chemical synthesis.
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Table 1.1 Sources of Astaxanthin
Sources

Astaxanthin (%) on a Dry
Weight Basis

References

0.01

(Yokoyama and
others 1995)

2.2

(Borie 2007)

Alphaproteobacteria
Agrobacterium aurantiacum
Paracoccus carotinifaciens (NITE SD
00017)
Chlorophyceae
Haematococcus pluvialis

3.8

Haematococcus pluvialis (K-0084)

3.8

Haematococcus pluvialis (Local
isolation)

3.6

Haematococcus pluvialis (AQSE002)

3.4

Haematococcus pluvialis (K-0084)

2.7

Chlorococcum

0.2

Chlorella zofingiensis

0.001

Neochloris wimmeri

0.6

(Ranga and others
2009: Ranga Rao
and others 2010)
(Aflalo and others
2007)
(Torzillo and others
2003)
(Olaizola 2000)
(Wang and others
2013)
(Zhang and Lee
1997; Zhang and
others 1997)
(Wang and Peng
2008)
(Orosa and others
2000)

Florideophyceae
Catenella repens

0.02

(Banerjee and others
2009)

Labyrinthulomycetes
Thraustochytrium sp. CHN-3 (FERM P18556)
Malacostraca
Pandalus borealis

0.2

(Yamaoaka 2008)

0.12

Pandalus clarkia

0.015

(EFSA 2005)
(Meyers and Bligh
1981)

Tremellomycetes
Phaffia rhodozyma

0.00001

Xanthophyllomyces dendrorhous (JH)

0.5

(table cont’d)
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(Kim and others
2005)

Astaxanthin (%) on a Dry
Weight Basis

References

Xanthophyllomyces dendrorhous (VKPM
Y2476)
Ulvophyceae

0.5

(de la Fuente and
others 2010)

Enteromorpha intestinalis

0.02

Ulva lactuca

0.01

Sources

(Banerjee and others
2009)
(Banerjee and others
2009)

1.3.2.2 Seafood byproducts
Astaxanthin is the primary naturally occurring pigment in marine crustaceans and in the
flesh of salmonids (Felix-Valenzuela, 2001). Unable to synthesize the pigment, these marine
creatures obtain the astaxanthin from their environment, or if farmed commercially, through their
feed. Byproducts from crustaceans are produced during processing operations for recovery of the
edible portion of crabs, crawfish, shrimp, and lobster; and consist of mineral salts, proteins,
chitin, lipids, and pigments. Natural marine fishery sources of astaxanthin are salmon, trout, krill,
crawfish and shrimp (Ambati et al., 2014). Astaxanthin, the predominant carotenoid found in
crustacean waste is free or esterified with fatty acids (De Holanda & Netto, 2006; Kim, Perera,
Rajapakse, & Kim, 2014). Crab, salmon and shrimp can serve as dietary sources of astaxanthin
(Authority, 2005)
1.3.2.3 Chemical synthesis
There are 5 C40 carotenoids manufactured synthetically, from petroleum feedstocks, on
an industrial scale (i.e. including ß,ß-carotene, lycopene, canthaxanthin, zeaxanthin, and
astaxanthin) for use as nutritional supplements and for animal feed additives in poultry farming
and aquaculture that are essential for the animals' growth, health and reproduction (Jackson et al.,
2008). The most widely used method of producing synthetic astaxanthin is the Wittig reaction is
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produced in an isomeric form similar to the form predominately found in nature (Ernst, 2002).
Synthetic astaxanthin is a racemic mixture (1:2:2:1) of all three-isomers (3S, 3S’), (3R, 3R’),
(3S, 3R’) and (3R, 3S’), respectively) as seen in Fig 1.6 (I. Higuera-Ciapara et al., 2006).
Synthetic astaxanthin is identical molecularly to that produced in living organisms, and is the
main carotenoid used in the aquaculture industry throughout the world (I. Higuera-Ciapara et al.,
2006).

Figure 1.6. Synthetic astaxanthin stereoisomers. Source: I. Higuera-Ciapara et al. (2006)
Studies have shown that both natural and synthetic astaxanthin produce satisfactory
effects, but human trials for natural astaxanthin are lacking due to production availability as
evidence by several studies. Furthermore, there has not been any established recommended dose
for astaxanthin daily intake, however most research findings report benefits from a daily intake
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of 4mg. Despite the low cost for manufacturing synthetic carotenoids, there is a deleterious
impact on the environment, and growing health concerns, there is an increasing demand for more
natural sourced compounds; this has led many researchers to investigate natural sources of
astaxanthin, such as crustacean byproducts (Cheng & Yang, 2016; Dalei & Sahoo, 2015; Gateau,
Solymosi, Marchand, & Schoefs, 2017; Gupta, Jha, Pal, & Venkateshwarlu, 2007; Ye, Jiang, &
Wu, 2008).
1.3.3

Uses of Astaxanthin
Astaxanthin has several patented applications available in feed, food, nutraceutical and

pharmaceutical applications (Ambati et al., 2014). Nutraceuticals are physiologically beneficial
foods that protect against chronic diseases (Hughes, Marangoni, Wright, Rogers, & Rush, 2009).
AX products are available in many different forms, from capsules, soft gels, tablets and energy
drinks to powder, oil, biomass, cream, oil and extracts.
Mammals, fish and crustaceans are unable to synthesize astaxanthin de novo, thus it must
be obtained from their diet, or partly modified through metabolic reactions (Liaaen-Jensen, 1990,
1998; Maoka, 2011; Matsuno, 2001). In nature astaxanthin, biosynthesized in plants, algae, and
some bacteria and fungi, is absorbed (dietary) and metabolized by mammals, fish and
crustaceans (H.-M. Chen & S. P. Meyers, 1982) accumulating in the skin, muscle or exoskeleton.
That results in the colors seen in flamingos, salmon, shrimp crawfish and rainbow trout (Shahidi
& Synowiecki, 1991).
1.3.4 Recovery of Astaxanthin
Several techniques have been used to extract astaxanthin from microorganisms
(microalgae, bacteria, and yeast), marine organisms (shrimp, crabs, crawfish and lobster) and
wastewater. Such techniques include acid, alkaline, and enzymatic treatments, vegetable oils and
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solvents with supercritical fluid extraction, ultrasound-assisted extraction, and ultrafiltration
(Amado, González, Murado, & Vázquez, 2016; Gimeno et al., 2007; Qing, 2010; N. Sachindra &
Mahendrakar, 2005; Sánchez-Camargo, Meireles, Ferreira, Saito, & Cabral, 2012).
1.3.4.1 Organic Solvents
Recovery of carotenoids (astaxanthin) from crustacean species have also been done using
acetone, ethanol, methanol, isopropyl alcohol and ethyl acetate. N. Sachindra, Bhaskar, and
Mahendrakar (2006) found that, compared to acetone, ethanol, isopropyl, methanol, petroleum
ether, and ethyl acetate, a 50:50 mixture of isopropyl alcohol and hexane gave the highest
carotenoid extraction yield (43.9 μg/g waste).
Extraction of astaxanthin with the use of solvents include supercritical (SC) fluid
extraction (SFE) using carbon dioxide (CO2) and a co-solvent, like an organic solvent (i.e.
ethanol). This extraction technique offers several advantages including low temperatures, low pH
to stabilize astaxanthin, and minimal to no oxygen and light exposure to cause oxidative or
thermal deterioration (Charest, Balaban, Marshall, & Cornell, 2001; Torrissen, Tidemann,
Hansen, & Raa, 1981). Studies using SC-CO2 with ethanol, showed a significant increase in the
extraction yield astaxanthin compared to SC- CO2 without ethanol (Charest et al., 2001; Nobre et
al., 2006; Sánchez-Camargo et al., 2012).
1.3.4.2 Acids and Enzymes
Depending on the condition for extracting carotenoids, some techniques have resulted in
50% losses of the carotenoid. To lessen the deleterious effects of certain techniques, pretreatment
steps are suitable to increase the efficacy of extraction methods. Such pretreatment alters the
matrix that carotenoids may be bound to. Barzana et al. (2002) use of enzymes to extract
carotenoids from marigold flowers (Tagetes erecta) eliminated silage and drying processes that
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resulted in considerable degradation of lutein, the predominate carotenoid. As mentioned before
natural carotenoids are found in crustaceans as a carotenoprotein (protein-pigment) complex.
Separating the carotenoprotein complex with enzymatic pretreatment prior to solvent extraction
yielded a greater concentration of astaxanthin in hydrolyzed (38.91 μg/g) samples, compared to
nonhydrolyzed (27.89 μg/g) samples (Armenta-Lopez 2002).
1.3.4.3 Edible Oils
Astaxanthin is a lipid soluble pigment, thus, many edible oils have been used as solvents
to extract this pigment from crustaceans and fish byproducts (H. M. Chen & Meyers, 1984;
Shahidi & Synowiecki, 1991). Such edible oils are mainly vegetable origin. N. Sachindra and
Mahendrakar (2005) used different vegetable oils such as groundnut oil, sunflower oil, gingerly
oil, coconut oil, rice bran oil, and mustard oil to compare extraction yields of carotenoids from
shrimp byproducts and concluded that refined sunflower oil gave the highest extraction yield. In
a study by Pu, Bechtel, and Sathivel (2010), flaxseed oil was used to extract astaxanthin from
shrimp byproducts. It was noted that astaxanthin lowered the oxidation rate of the flaxseed oil.
Additionally, (Krichnavaruk, Shotipruk, Goto, & Pavasant, 2008) SC- CO2 extraction of
astaxanthin from H. pluvialis was done with the soybean oil and olive oil. The highest extraction
efficiency obtained, of 36.36 ± 0.79% and 51.03 ± 1.08%, respectively, was obtained and was far
greater than what was extracted with pure SC- CO2 (25.4 ± 0.79%).
The major pigments in oil extract are monoesters and diesters, suggesting that these esters
are preferentially extracted by the oils. The extracted, esterified astaxanthins are considered to be
less prone to oxidation than free astaxanthin (Omara-Alwala, Chen, Ito, Simpson, & Meyers,
1985). Free astaxanthin is either esterified with one or two fatty acids (FAs), or conjugated to
proteins (carotenoprotein complex), such as in salmon and mussel muscle or snow crab and
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lobster exoskeleton (Guerin et al., 2003; Henmi, Hata, & Hata, 1989; Manu-Tawiah & Haard,
1987; Ya et al., 1991; H.-P. Yang, Lee, Kim, & Kim, 1994)
1.3.4.4 Ultrasound Assisted Extraction
The major markets of astaxanthin sourced from H. pluvialis are nutraceutical and
aquaculture markets. Inexpensive and less harsh physicochemical and cell disruption extraction
methods (reduced toxicity and contamination from chemicals/solvents, and reduced structural
changes by thermal treatments) are needed to yield increased amounts of naturally derived
bioactive astaxanthin.
Novel extraction techniques have received a great deal of attention to overcome
drawbacks of conventional extraction techniques. Drawbacks of conventional methods include
the use of large amounts of solvents, exposure to elevated temperatures, lower extraction yields
and prolonged extraction times. Novel techniques include supercritical carbon dioxide (SC- CO2)
extraction, microwave assisted extraction, and ultrasound assisted extraction (UAE). UAE has
been used to extract and detect compounds in animals' structures and plant tissues (Kadam,
Tiwari, & O’Donnell, 2013; Nessa, Khan, & Al Khatib, 2010; Vinatoru, Mason, & Calinescu,
2017; Yue, Xu, Prinyawiwatkul, & King, 2006).
Several proposed theories exist for explaining the extracting enhancement of UAE (F.
Chemat et al., 2017). For extraction of astaxanthin from H. pluvialis, the theory of operation may
be described as a detexturation effect. Detexturation of plant structures were noticed in a study
on essential oil extraction by S. Chemat, Lagha, AitAmar, Bartels, and Chemat (2004). In their
study, scanning electron micrographs showed gradual physical alterations (degradation of cell
walls) with increasing processing times, between conventional extracted and UAE of caraway
seeds used as a model compound. Such characteristic cell wall degradation favors accessibility of
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the solvent to the intracellular components, rather than relying on diffusion alone, as in
conventional extraction techniques. In a separated study modeling the extraction of astaxanthin,
UAE improved the extraction efficiency of astaxanthin, when chemical and mechanical cell
disruptions techniques were compared (D. Singh et al., 2015).
1.4

Lipid Digestion and Absorption
The gastrointestinal (GI) system, Figure 1.7, is responsible for the digestion and

absorption of lipids. There are specific processes involved in the digestion and absorption of
dietary lipids through the water-soluble environment of the GI tract (Lichtenstein & Jones,
2012). Dietary lipids (TG, phospholipids, steroids, and fat-soluble bioactive compounds) may be
liquid or solid depending on temperature, and are referred as fats and oils, respectively. The bulk
of dietary lipids are TG, which consist of a glycerol molecule esterified to three FAs.
1.4.1

Digestion

The first step of digestion begins in the mouth with salivation and mastication. Lohse et al
(2007) suggested lingual lipase, produced by von Ebner’s glands, starts the hydrolysis of free
FAs from triacylglycerols (TAGs). TAGs are cleaved at the sn-3 position by lingual lipase, with
increased efficiency towards short-chained FAs (Carey, Small, & Bliss, 1983). Carriere et al.
(1993) reported that in the stomach, hydrolysis of TAGs continues with gastric lipase, secreted
by chief cells of the gastric mucosa. Gastric lipase also cleaves TAG at the sn-3 position
(Lichtenstein & Jones, 2012). The fat entering the upper duodenum is approximately 70% TG
while the remainder is a mixture of partially digested hydrolysis products known as chyme.
The small intestine, the site where the majority of lipid digestion and absorption occurs,
requires the actions of bile salts and pancreatic lipase, the principle enzyme involved in TAG
digestion , which hydrolyzes ester bonds at the sn-1 and sn-3 positions (Canaan, Roussel, Verger,
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& Cambillau, 1999; J.H.Peter & Rideout, 2010; Mu & Høy, 2004). Bile salts, phospholipids, and
sterols are all lipid components of bile. Bile, an emulsifying fluid, is secreted directly from the
liver and stored in the gall bladder in response to the presence of fat in the duodenum
(Lichtenstein & Jones, 2012). The gall bladder also secretes pancreatic lipase. During digestion,
lipids dissolve hydrophobic compounds and cause an increase in the secretion of bile from the
gall bladder, which subsequently leads to the micellization of lipids (Hughes et al., 2009).
Dietary mixed micelles are formed in the small intestine by 2-monoaclyglycerol and free FAs
(hydrolytic products of TAG), bile salts, phospholipids, unesterified cholesterol, and other fatsoluble substances (Salvia-Trujillo et al., 2017). Subsequently, the decreased size of the formed
micelles and increased surface area over larger droplets aids in further solubilization and
digesrtion of carotenoids (Furr & Clark, 1997).

Figure 1.7. Gastrointestinal system anatomy. Source: https://www.saintlukeskc.org/healthlibrary/anatomy-digestive-system.
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1.4.2

Absorption of Carotenoids: Astaxanthin
A number of factors, described by the mnemonic “SLAMENGHI”, affect the absorption

of carotenoids. Species, Linkage, Amount of carotenoid consumed in a meal, Matrix, Effectors,
Nutrient status, Genetic factors, Host-related factors, and Interactions (Castenmiller & West,
1998; Lindshield, 2012). Species refers to the carotenoid being a xanthophyll or carotene, and
relates to it geometric isomerism (BeMiller, 1986) The molecular linkage, whether free or
esterified to FAs, is important for absorption also. The matrix refers to the accessibility of the
carotenoids, being unbound or bound, becoming solubilized in micelles within the GI tract
(Lindshield, 2012). It is critical for absorption to free carotenoids from bound matrices to
improve uptake and increase bioavailability. Many effectors may contribute to the efficient
absorption and bioconversion of carotenoids.
Diets consisting of many fruits and vegetables delay the onset of many age-related
diseases, and contain a complex mixture of antioxidants (ascorbic acid, vitamin E, flavonoids,
and carotenoids) (Everitt et al., 2006; S. Wang, Melnyk, Tsao, & Marcone, 2011). Since
carotenoid are lipi-soluble, their absorption follows that of dietary fats. Additionally, intestinal
absorption of carotenoids involves several critical steps: 1) release from the food matrix, 2)
solubilization into mixed micelles in the lumen, 3) cellular uptake by intestinal mucosal cells, 4)
incorporation into chylomicrons and 5) secretion of carotenoids and their metabolites associated
into the lymph (E. H. Harrison, 2012). A number of factors affect the absorption of carotenoids,
like species, linkage, amount, matrix, effectors, nutrient status, genetic factors, host-related
factors, and interactions (Lindshield, 2012). Species refers to the carotenoid belonging to a
group, xanthophyll or carotene, and relates to its geometric isomerization. However, the
bioavailability of carotenoids is low, and varies from more than 50% in oily solutions to less than
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10% from raw uncooked vegetables (Hinnant, Oh, Caburnay, & Kreuter, 2011; Olson, 1999).
This low bioavailability reduces the distribution within the body by lowering the efficacy and
potency of the carotenoid’s therapeutic effects. Between the two groups of carotenoids,
xanthophylls are ordinarily more readily absorbed than carotenes in part due to their hydrophobic
nature, allowing them to be incorporated into the outer portion of lipid micelles in the lumen
preceding absorption (Mercke Odeberg, Lignell, Pettersson, & Höglund, 2003; Yeum & Russell,
2002).
Bioavailability of astaxanthin is also be dependent upon digestion, intestinal absorption,
and delivery to tissues (Couëdelo et al., 2010). The molecular linkage, whether free or esterified
to FAs, is important for absorption. The matrix refers to the accessibility of the carotenoids,
being unbound or bound, becoming solubilized in micelles in the GI tract (Lindshield, 2012).
Many effectors contribute to the efficient absorption of carotenoids. Bioavailability of
carotenoids is affected by the presence, amount, and type of lipid in the digestive tract at the time
of absorption (Hughes et al., 2009).
Distribution of carotenoids among lipoproteins varies between carotenes and
xanthophylls. The hydrophobic carotenes are found predominately in low-density lipoproteins.
Guerin et al. (2003), reviewed the steps of digestion, absorption and plasma transport of
carotenoids in mammals and found that polar carotenoids, such as astaxanthin, are likely to be
transported by low-density lipoproteins (LDLs) and high-density lipoproteins (HDLs). Humans
(along with monkeys, gerbils, and ferrets, but excluding rats, and mice unless given very high
doses) absorb a significant portion of intact carotenoids directly and circulate or accumulate
them in their plasma, liver, and peripheral tissue (X.-D. Wang, 2012). Things like vitamin A
status, protein deficiency, and iron status are also known to affect absorption efficiency. Host
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illnesses like atrophic gastritis, the process of chronic inflammation of the stomach mucosa,
decreases carotenoid uptake due to insufficient gastric acid secretion, which disturbs the
formation and absorption of mixed micelles (Yeum & Russell, 2002).
During digestion, lipids dissolve hydrophobic compounds and increase bile secretion
from the gall bladder, which in turn leads to their solubilization for micellarization (Hughes et
al., 2009). Inefficient absorption of astaxanthin may be due to several factors; including
astaxanthin being embodied in food matrices, dissolution limitations in the GI fluids (E-isomer),
and a saturated capacity of incorporation into bile micelles (Parker, 1996). X.-D. Wang (2012)
suggested that food processing that causes mechanical breakdown of the food matrix and
subsequent release of carotenoids can improve intestinal absorption, as in boiling of crustaceans
like shrimp and crawfish.
1.5

Flaxseed Oil
In addition to the many health protecting benefits that AX has to offer and the potential to

use an otherwise discarded material which may present environmental concerns, it would be
ideal to use crustacean processing byproduct material as a natural source. A simple food
processing method or heating can cause the mechanical breakdown of the matrix and release of
the carotenoid, AX, from the processing byproducts (X.-D. Wang, 2012). Additionally, since AX
is a lipophilic compound it can be extracted from processing byproducts using many plant
derived edible oils, such as flaxseed oil.
Flaxseed oil, cold pressed from flax (Linum usitatissimum), or linseed, has gained a lot
of attention due to its exceptional nutrient profile and protective effects against cardiovascular
disease, inflammation, and some cancers (Bloedon & Szapary, 2004; C. R. Harper, Edwards,
DeFilipis, & Jacobson, 2006; Tzang et al., 2009). Flax is the richest plant source of a-linolenic
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acid (ALA; C18:3n-3), an omega-3 (n3) FA and lignans (phytoestrogens) (Barceló-Coblijn et al.,
2008; Goyal, Sharma, Upadhyay, Gill, & Sihag, 2014; Oomah & Agriculture, 2001).
The importance of fat, and its lack thereof to severely impact growth and reproductive
development in experimental animals was demonstrated by Evans and Burr (1927), despite the
administration of fat-soluble vitamins. The works of the Burrs led to the discovery that FAs were
crucial to health, and a deficiency could often lead to death. ALA is considered an essential fatty
acid (EFA), a term coined by Burr and Burr (1930) for those FAs not synthesized by mammals
and for which deficiencies could be reversed by dietary FA addition. ALA is a precursor of the
n-3 FA family, the other being linoleic acid (LA); neither can be synthesized, in vivo (Jeffcoat &
James, 1984). In vivo synthesis cannot occur because mammals lack the desaturase enzymes
required to synthesize double bonds at the n-3 and n-6 position of the carbon chain of FAs.
Therefore n-3 and n-6 FAs must be obtained from the diet (Jeffcoat & James, 1984; J. Lee, Lee,
Kang, & Park, 2016). ALA is also a precursor to the long chain (n-3) polyunsaturated FAs
(PUFA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (C. R. Harper et al.,
2006).
Of the total lipid content in flaxseed, thirty percent is composed of 100% lipids, of which
53% are ALA, 17% LA, 19% oleic acid, 3% stearic acid, and 5% palmitic acid; all of which
provide an excellent n-6: n-3 FA ratio of approximately 0.3:1 (Simopoulos, 2002).
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Table 1.2. Fatty acid content of flaxseed oil
Fatty Acids
Percentage (%) (Range)
Palmitic acid (C16:0)
4.90-8.00
Stearic acid (C18:0)
2.24-4.59
Oleic acid (C18:1)
13.44-19.39
Linoleic acid (C18:2) (⍵-6)
12.25-17.44
39.99-60.42
⍺-Linolenic acid (C18:3) (⍵-3)
Sources: (Anwar, Zreen, Sultana, & Jamil, 2013; Bozan & Temelli, 2008; Choo, Birch, &
Dufour, 2007a; Guimarães et al., 2013; Khattab & Zeitoun, 2013; Pradhan, Meda, Rout, Naik, &
Dalai, 2010; Pu et al., 2010; Quispe-Condori, Saldaña, & Temelli, 2011; Z.-S. Zhang et al.,
2008; Z.-S. Zhang, Wang, Li, Li, & Özkan, 2011).
Flaxseed oil is low in saturated FAs, moderate in monosaturated FAs, and rich in PUFAs
(polyunsaturated fatty acids), with ALA being the major FA (Table 1.2) (Goyal et al., 2014).
Flaxseed oil provides the highest amount of ALA (40-60 wt% of total FAs) among various
vegetable sources (Couëdelo et al., 2010). In other words, The antioxidant properties of ALA,
like cardio protection, and other beneficial health effects of ALA have been attributed to its
precursor role in converting to EPA in the body (Rajaram, 2014).
1.6

Lipid Oxidation
The general term used to describe complex sequences of chemical changes that result

from the interactions between lipids and oxygen is known as lipid oxidation, or autooxidation at
times (Damodaran & Parkin, 2017). Lipid oxidation can either be mediated by enzymes (i.e.
lipoxygenase, cytochrome P450s, and cyclooxygenases), nonenzymatic and nonradical
photooxidation, or by nonenzymatic chain autoxidation pathways (i.e. reactions with oxidants
and free radicals mentioned in the following paragraphs). Both enzymatic and non-enzymatic
oxidation pathways are responsible for physio-pathological effects seen in cellular functions and
the development of diseases (Figure 1.8). The last two types of reaction pathways consist of a
combination of reactions involving triplet oxygen 3O2.
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PUFAs are more readily attacked by oxidants because of the high number of carboncarbon double bonds contained within their structure (Ayala, Muñoz, & Argüelles, 2014).
Additionally, the high susceptibility of lipids to oxidation is the reason why they are an excellent
energy source for catabolic metabolism. Lipid oxidation of foods containing lipids during food
processing and storage is of major concern because it can create undesirable qualities in a
finished product. Lipid oxidation can be initiated (ensue the formation of free radicals) by a
number of factors (initiators) including heat, UV and ionizing radiation, peroxides and trace
metals (i.e. copper or iron ions), reaction (1):
3

*+

sens ,- 1sens + 3O2 → 1O2

(1)

Figure 1.8. Lipid oxidation occurring through both enzymatic and non-enzymatic reactions.
Source: Sottero et al. (2019)
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During lipid oxidation, the hydroperoxides formed from unsaturated FAs like linoleic acid (LA;
C18:2n-6) and arachidonic acid (AA; C20:4n-6) readily undergo autoxidation, the key
mechanism in lipid oxidation, due to the ease of which a hydrogen atom can be abstracted from
the molecules, forming a free radical. Meaning, the autoxidation rate increases with the degree of
unsaturation in lipids. The processes of lipid oxidation follow the same order regardless of it
being in an emulsion or other food product as it does in an oil, and are discussed in further detail.
Nonenzymatic FA oxidation, also termed autooxidation, can be described by three distinct
phases, known as initiation, propagation and termination.
1. Initiation
It is unlikely for the non-enzymatic unsaturated FA (LH) oxidation, reaction (2), to
proceed spontaneously because of the high activation energy resulting from the spin barrier
between lipids and 3O2(Laguerre, Lecomte, & Villeneuve, 2007). Therefore, it begins with the
homolytic breakdown of hydrogen in the
LH + 3O2 à LOOH

(2)

During this step, peroxides are cleaved and formed into alkoxy and hydroxyl radicals and act as
initiators of subsequent chain reactions (Halliwell & Chirico, 1993). During this initiation step,
unsaturated FAs (chemical species) with unpaired electrons called the alkyl radical (L*), are
formed. Lipid oxidation is mostly initiated by hydroxyl (*OH) and hydroperoxyl (HOO*) radicals
(reaction (3)). Additionally, lipid alkoxyl (LO*) and peroxyl (LOO*) radicals (reaction (4)) can
act as initiators as well. Hydroxyl radicals have the highest reaction rate with lipids; thus, the
importance of their reduction is crucial to oxidative stability. Antioxidants can counteract lipid
oxidation by protecting FAs from oxidation initiators or by stalling the second phase,
propagation (intercepting radical oxidation propagators).

27

LH + 3O2 à L* + *OH

(3)

L* + O2 à L* + LOO*

(4)

2. Propagation
The propagation phase is primarily a radical chain reaction. During this phase, peroxide
radicals react with oxygen to form a peroxyl radical (LOO*) which potentially accelerates lipid
degradation due to its high energy (reaction (5)). Hydrogen addition to the peroxyl radical
results in the formation of hydroperoxides (LOOH) and a new L*, the primary oxidation
compounds that can react with other radicals to form volatile compounds (reaction (6)). In order
to slow down this reaction, the oxygen level should be very low, or an antioxidant can be used to
intercept lipid peroxyl (LOO*) radicals, a radical oxidation propagator (Laguerre et al., 2007).
LOO* + LH à L* + LOOH

(5)

LOOH à LO* + *OH

(6)

3. Termination
The propagation phase persists with the transformation (decomposition) of
hydroperoxides into secondary nonradical compounds. The termination reactions leads to the
formation of hydrocarbons (dimers), volatile and nonvolatile ketones, alcohols, and oxidized
triacylglycerols and polymers (Halliwell & Chirico, 1993; Laguerre et al., 2007). When
polyunsaturated FAs oxidize and become alkyl radicals (R*), they form FA dimers (R-R) and
hydroperoxide dimers (R-OO-OO-R), the major initial oxidation products susceptible to further
oxidation or decomposition to secondary reaction products (i.e. short-chain aldehydes, dimers
(reaction (6)), ketones (reaction (7)) and other oxygenated (non- radical) compounds (reaction
(8))). A single polyunsaturated hydroperoxide radical (ROO*), primary oxidation compound, can
generate several types of volatile or nonvolatile molecules.
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R* + R* à R-R

(7)

R* + ROO* à R-OO-OO-R

(8)

ROO* + ROO* à ROOR + O2

(9)

The secondary reaction products may undesirably affect the overall quality of foods, including
flavor, odor, nutritional value and the production of toxic compounds that cause diseases,
especially within anaerobic environments, i.e., frying oils (Spickett et al., 2015; Vercellotti, St
Angelo, & Spanier, 1992).
1.7

Hydrocolloids
Colloids (e.g., proteins, starches, and fats), never truly dissolve in a solvent, but remain in

an unstable colloidal dispersion. These dispersions contain particles larger than molecules, yet
too small to be seen. Hydrocolloids are colloids with an affinity for water. as defined by the
etymology of the word. Hydrocolloid, of Greek origin with hydro meaning ‘water’ and kolla
meaning ‘glue’ (Wüstenberg, 2015). Natural hydrocolloids are biopolymers that originate from
living organisms. Additionally, hydrocolloids will increase the viscosity an aqueous system and
all will bind and hold water to different extents. The two main uses of hydrocolloids are
thickening agents in soups, gravies, and sauces and the other use is as a gelling agent is jams,
jellies and low sugar gels (Saha & Bhattacharya, 2010). A gel is defined as a largely diluted
system that exhibits no steady flow (Ferry, 1980). Gels are typically made of polymers crosslinked by covalent or non-covalent interactions to form a network capable of entrapping water
and low molecular weight materials. Simply stated, a gel is a transitional phase between a solid
and a liquid. A few other functional properties include film formation, encapsulation, and
improving shelf-life (Paulomi Burey, Bhandari, Howes, & Gidley, 2008; Dickinson, 2003,
2009).
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A secondary function of hydrocolloids is reducing the flavor intensity by increasing a
food products thickness. These are all important factors when formulating a food product or a
delivery system. Even though most hydrocolloids are polysaccharides from natural sources like
pectin from citrus peels and apple pomace, and carrageenan from seaweed, some are proteins,
like gelatin from collagen from animals, and gliadin from wheat (BeMiller, 2008; Paulomi Burey
et al., 2008; Endress & Christensen, 2009; Mariod & Fadul, 2013; X. Wang, Chen, & Lü, 2014).
The hydrocolloids gelatin and pectin are two biopolymers capable of forming a gel, the
in-between phase amid a solid and a liquid. A gel is defined as a largely diluted system that
exhibits no steady flow (Ferry, 1980). Simply stated, a gel is a transitional phase between a solid
and a liquid. Gels can be made up of polymers cross-linked by covalent or non-covalent
interactions to form a network capable of entrapping water and low molecular weight materials.
Gelation is defined as the phase transition from a state without a gel to a state with a gel, that
involves the formation of an “infinite” network (Stauffer, Coniglio, & Adam, 1982).
1.7.1

Gelatin
Gelatin, Figure 1.9 is obtained from the partial hydrolysis of the polypeptide backbone of

collagen from pigskin, cattle bones and cattle hide (46%, 29.4%, 23.1% of total production,
respectively) (Duconseille, Astruc, Quintana, Meersman, & Sante-Lhoutellier, 2015; Karim &
Bhat, 2008). The name gelatin is derived from the Latin gelata, describing the most
characteristic quality, i.e. gel formation in water (Ledward, 2000). First used as a glue as far back
as 600 B.C., gelatin, a biopolymer made of water-soluble protein (85-92%), belonging to a
unique class of hydrocolloids that have many functions and applications, is now used as a food
and pharmaceutical ingredient for its gelling and foaming ability (Duconseille et al., 2015; Karim
& Bhat, 2008). Gelatin is also an essential ingredient in the preparation of a confectionery with a
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hard, chewy or foamy texture. There are two types of gelatin, type A from acid (mineral acid, pH
1.5 to 3.0) pretreatment, and type B from alkaline (saturated lime, pH 12.0) pretreatment. In the
pharmaceutical industry gelatin in the main ingredient used in making hard capsules. A key
feature of such capsules is that they melt at temperatures above 30 ºC enabling them to easily
release encapsulated drugs they contain in the human digestive tract. In addition to gelatin
possessing the ability to form a gel, they can act as an emulsifier and stabilizers of colloid
systems.

Figure 1.9. Chemical structure of gelatin.
1.7.2

Hydroxypropyl methylcellulose (HPMC)
An alternative to gelatin, hydroxypropyl methylcellulose (HPMC, Figure 1.10) was

developed in the industry from other polymers in an attempt to replace gelatin due to regulatory
concerns and drug incompatibility (Al-Tabakha, 2010; Duconseille et al., 2015). HPMC is a
synthetic modification of the natural polymer cellulose, the most common organic compound
and biopolymer on earth. HPMC has been used as a thickening agent, as a coating polymer, in
controlled release systems, and even in solid dispersions to enhance drug solubility (C. L. Li,
Martini, Ford, & Roberts, 2005). A major defining difference between biopolymers and synthetic
polymers can be found in their structures.
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Figure 1.10. Chemical structure of hydroxypropyl methylcellulose (HPMC). Source: Phadtare,
Phadtare, Nilesh, and Asawat (2014)
1.7.3

Pectin
Pectin, a biopolymer with stabilizing and gel forming capabilities, is an anionic

polysaccharide complex of branched heteropolysaccharides from the middle lamella and cell
walls of plants, consisting of partially esterified galacturonic acid residues, see Figure 1.11
(Baciu & Jördening, 2004). Pectin for the commercial industry is mainly derived from apple
pomace and citrus peel, byproducts from juice manufacturing. Even though pectin’s are found
most commonly in terrestrial plant tissues and cell walls, they do not all possess the ability to
form gels. The gel forming ability of pectin depends on the molecular weight and the degree of
methylation (DM) (Thakur, Singh, Handa, & Rao, 1997). The DM is particularly important when
considering the formulation of a drug delivery system (Ashford, Fell, Attwood, Sharma, &
Woodhead, 1994), that targets specific sites within the digestive system. Pectins with low
degrees of methylation (LM pectin), DE < 50%, are relatively soluble but can be cross-linked by
divalent cations (calcium, Ca) to produce insoluble gels. Conversely, pectins with high degrees
of methylation (HM pectin), DE > 50%, are poorly soluble, and gel with high concentrations of
sugar (Löfgren & Hermansson, 2007; Rolin, 1993). Additionally, pectin can be used to
encapsulate bioactive compounds.
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Figure 1.11. Structure of pectin. Alpha 1, 4 linked D-galacturonic acid. Source: Ali, El-Regal,
and Saeed (2015)
1.7.4

Interactions of protein and polysaccharides
There are multiple interactions known to occur between proteins and polysaccharides.

These specific and non-specific interactions cannot be fully understood without prior research,
and are critical in formulations. Interactions of polysaccharides and protein range from complete
segregation to complexation (Figure 1.12). Both proteins and polysaccharides are present
together in many food systems, contributing to the structure, texture, and stability of the food
independently, through their surface properties and distinctive thickening or gelling behavior.
Albeit the vast information known at the molecular level about the functionality of individual
biopolymers, our knowledge of the role of protein-polysaccharide interactions, as it relates to
their functionality in emulsions, gels or food mixed solutions is somewhat limited.
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Figure 1.12. Main trends in the behavior or biopolymer mixtures. Source: P. Burey, Bhandari,
Rutgers, Halley, and Torley (2009).
Biopolymer interactions in food systems are typically thermodynamically characterized
by separating them into enthalpy or entropy driven types. Properties of food products, i.e., flow,
stability, texture, and mouthfeel, are all influenced by protein-polysaccharide interactions in the
aforementioned thermodynamic categories. When mixing two biopolymers in solution, one of
the three possibilities depicted in Figure 1.12 may be observed. The resulting interactions will
either be segregative or associative. However, in very dilute solutions the proteins and
polysaccharides are co-soluble. Conversely, upon increasing the concentrations of the
biopolymers, the co-solubility may be lost. Biopolymer mixtures tend to segregate more often
than not (de Kruif & Tuinier, 2001).
The association between protein and polysaccharide molecules can occur chemically
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through covalent bonds or physically through electrostatic interactions. Attraction and repulsion
are the two major types of interactions that occur between proteins and polysaccharides in
solution that may result in complex formations (coacervation), co-solubility or immiscibility of
the two biopolymers as seen in Fig. (Benichou, Aserin, & Garti, 2002). The electrostatic
attraction between pectin and gelatin leads to complexation and coacervation.
Bungenberg de Jong (1949) first described the formation of coacervates and complex
coacervates. In general, coacervates are formed reversibly. The word coacervate was used
because the complex remained liquid, rather than precipitated. This is a phenomenon that occurs
quite often in biopolymer mixtures in which the biopolymers are oppositely charged.
Many polysaccharides carry anionic groups; pectin and gum arabic (GA), for instance,
carry carboxylic groups. Pectin contains anionic groups (carboxylic groups) in its structure that
are negatively charged, while other polysaccharides contain phosphate and sulphate groups.
Gelatin, being an ampholytic protein, can form a complex coacervate with polysaccharides.
Gelatin being ampholytic means it is anionic at pH > pI and cationic if pH < pI, where pI is the
iso-electric pH, defined as the pH where the net charge is zero. Gelatin also carries many lysine
groups and can therefore be used to form complexes with anionic polysaccharides such as pectin.
A complexation of this type is used in encapsulation. For instance, GA is adsorbed onto an oil–
water interface together with gelatin, thus ‘coating’ the oil droplet with both biopolymers. In this
way one can use biopolymers as emulsifier although they do not adsorb onto emulsion droplets
without the other biopolymer.
Like many other carotenoids, being non-polar and lipid-soluble, the absorption of
astaxanthin is enhanced with dietary oils (Ambati et al., 2014; Erdman, Bierer, & Gugger, 1993;
Fernández-García et al., 2012; Parker, 1996). Considering the previously discussed factors
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affecting the absorption and bioavailability of astaxanthin, it is important to consider a delivery
system to improve upon those affected processes. The metabolic fate of bioactive compounds in
vivo does not depend solely on intrinsic factors; however, it is more determined by the carrier
system. Based on human physiology and the mechanism of lipid absorption, the incorporation of
such astaxanthin into a delivery system for intestinal uptake and absorption would be beneficial.
In efforts to overcome the susceptibility of bioactive compounds to a loss of function or
destruction and improve their stability during processing and storage, emerging technologies of
nano-/micro-encapsulation are applied in food and nutraceutical industries. Besides protecting
them from the harsh processing conditions and adverse storage environment, the encapsulations
of bioactive compounds can also achieve targeted delivery and controlled release of entrapped
nutrients to the specific site. Encapsulation is a technique employed to create functional foods,
guaranteeing the stability of functional constituents while allowing their application to diverse
foods (Dias, Botrel, Fernandes, & Borges, 2017). Encapsulation is a process that creates a barrier
over the active component that protects against the effect of environmental factors and allows the
controlled release of the active component under certain conditions. Different delivery systems
including liposomes, emulsion and complex coacervates, are appropriate to create protective
barriers. However, complex coacervates, were chosen as the preferred delivery system due to its
key advantages of heat resistance and a higher loading capacity (Muhoza, Xia, Cai, et al., 2019).
The controlled release of bioactive compounds is needed to prevent such compounds
from being completely solubilized and immediately bioavailable following oral ingestion. To
accompany the immediate release of bioactive compounds after oral ingestion, a characteristic
pattern featuring high plasma concentrations of the compound shortly after ingestion ensues.
This is followed by a sharp decrease, as it is expeditiously absorbed into the bloodstream and
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cleared from the system (Turner et al., 2004).
Both increased free radical production and reduced antioxidant defenses both lead to
oxidative stress. Oxidative stress is defined as an imbalance between prooxidants (reactive
oxygen species (ROS) and other reactive metabolites, i.e. reactive nitrogen species) and their
elimination by antioxidants, which is in favor of the prooxidants (Reuter, Gupta, Chaturvedi, &
Aggarwal, 2010; Sies, 2013). As a result of oxidative stress, the production of biomarkers (i.e.
cytokines, protein carbonyls, and thiobarbituric acid reactive substances relating to lipid
peroxidation) is increased via several different mechanisms (Elmarakby & Sullivan, 2012; J. Liu
et al., 2000). The production of cytokines causes a cascade of additional cytokines to be secreted,
ultimately leading to deleterious effects on the body. Exercise increases rates of oxygen
consumption by the whole body and tissue causing oxidative stress and tissue damage (J. Liu et
al., 2000). However, this damaging response is attenuated if exercise is done repeatedly as the
tissue acclimates to the new overload stress
Studies suggest the addition of an antioxidant is required to achieve an overall positive
effect of dietary oils, as it relates to the further oxidation of components within the oil that
potentially lead to increased oxidative damage and shortening of the lifespan in animal models
(Tsuduki, Honma, Nakagawa, Ikeda, & Miyazawa, 2011). There is a synergistic effect between
AX and edible oils, for example AX may offer protection to the oil from oxidation and the oil
improves the stability and absorption of the AX. Studies have reported that carotenoids are
absorbed in the body like lipids and undergo the same transport mechanisms as does lipids.
Nonetheless, flaxseed oil is used to extract AX in order to create a carotenoid rich edible oil
(FOAX) that can be used in further processing steps to add nutritive value. The extraction of AX
using (flaxseed oil), to assess the effect of FO and AX together against oxidative stress as well as
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the synergy between the two, relating to slowing the oxidation of the FO and subsequently
creating a delivery system with the flaxseed oil (FO) containing AX (FOAX) to investigate the
transport of astaxanthin for absorption.
1.8

Cancer trends and treatment
Cancer, a collection of related diseases, impacts the lives of many people all around the

world. Cancer, occurring among men and women alike, can start almost anywhere in the body
(see Table 1.3). Recently it was projected for 2019 that 1,735,350 new cancer cases would occur
in the United States (Siegel, Miller, & Jemal, 2019). Of those projected new cases, 34.4% are a
result of patient mortality due to the disease. Cancer is the second leading cause of death
worldwide. With normal human physiological processes, cells grow and divide to form new cells
as the body requires. Those new cells take the place of old or damaged cells. Conversely, with
cancer the body’s cells divide without stopping, regardless of being damaged, and spread into
surrounding tissues potentially causing tumors.
Table 1.3. Percentile of the Projected (1,762,450) New Cancer Cases and Survival Rates
Cancer sites (part)
Oral
Breast
Digestive system
Esophagus
Stomach

Liver
Pancreas
Respiratory system
Lung
Skin
Melanoma
(table cont’d)

% of projected new
cases
3
15.4
18.6
1
1.5
5.8
2.4
3.2
13.9
12.9
5.9
5.4
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% Survival
79.5
84.4
8.9
59.5
49.7
24.4
19.4
37.4
92.5

Cancer sites (part)
Genital system
Ovaries
Prostate
Brain
Lymphoma
Leukemia
Source: Siegel et al. (2019)

% of projected new
cases

% Survival

1.3
9.9
1.4
4.7
3.5

37.9
81.9
25
74.5
63

Tumors can be either benign or malignant. As a malignant tumor, capable of spreading
into or invading neighboring tissues, some of the cancer cells may disassociate and travel to
other sites in the body through the blood or lymphatic system and form new cancerous tumors
(metastasizing). On the other hand, benign tumors do not spread or invade adjacent tissues.
Albeit benign tumors do not grow back after removal, some can be life threatening, like benign
brain tumors (Hill, Nixon, Ruehmeier, & Wolf, 2002).
Genes are fragile and a variety of things can damage them, including sunlight and how
they are copied during proliferation. In chromosomal DNA only 5 to 10 percent of all cancers are
genetic in origin. According to Glaire and Church (2019), cancer, a disease of a disordered
genome, is an unregulated, disproportionate division of cells. This is recognized pathologically
by a greater proportion of cells actively in the cell cycle than is ordinarily present in the normal
tissue from which it originated. Meaning a higher fraction of cells are in mitosis, recognizable by
microscopy, and a higher fraction of cells are in S-phase, where DNA replication occurs.
1.8.1

Breast Cancer
Of the 100 or so different types of cancer, breast cancer, the most common form of

cancer in women globally, is the second leading cause of deaths for women in the United States
(Boyle, 2012). About 12% of women in the United States will develop invasive breast cancer
over the course of their lifetime (Brocker, 2017; Friedman, 2018; Gemignani, 2016; J. Harrison,
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2019; Hill et al., 2002). Breast cancer comprises distinct subtypes that have different biological
and clinical behaviors. Researchers have defined four main classical subtypes of breast cancer
based on biological and clinical meaningfulness pertaining to how abnormal the cancer cells and
tissue look microscopically and how quick they are likely to metastasize (Weigelt, Geyer, &
Reis-Filho, 2010). The subtypes differ by their expression of the estrogen receptor (ER),
progesterone receptor (PR) and the human epidermal growth factor receptor 2 (HER2 positive)
(Tyanova et al., 2016).
ERs are nuclear receptors belonging to the steroid hormone receptor superfamily that
mediate the effects of the C18 sex steroid, 17ß-estradiol (E2), produced by the testis and ovaries
in both men and women, respectively (Enmark & Gustafsson, 1999; Hess et al., 1997). E2 has
primary effects on females during their reproductive and development years, while also playing a
critical role in male sexual function (Brock, Baum, & Bakker, 2011; Schulster, Bernie, &
Ramasamy, 2016). Darbre, Yates, Curtis, and King (1983) found that E2 increased the growth
rate of a human breast cancer cell line that is positive for ER expression. Similarly, a second
nuclear receptor belonging to the steroid hormone receptor superfamily, known as PR, mediates
the effects of the C21 sex steroid, progesterone (Scarpin, Graham, Mote, & Clarke, 2009).
Progesterone is critical for the normal reproductive function of women, and has been shown to
increase the proliferation of luminal epithelial cells (Clarke, Howell, Potten, & Anderson, 1997;
Masters, Drife, & Scarisbrick, 1977; Meyer, 1977; Potten et al., 1988). Cells that are ER/PRpositive are much more likely to respond to hormone therapy than those that are ER/PRnegative. HER2, a member of the epidermal growth factor family, when overexpressed is
associated with a more aggressive, decreased survival, and higher recurring form of disease
(Mitri, Constantine, & O'Regan, 2012). Lastly, there is a subtype known as, triple-negative
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Figure 1.13. The triple-negative breast cancer (TNBC) cells are so termed because they lack
expression of the ER, PR, and HER2 receptors. TNBC cells present a poor prognosis and are
considered to be more aggressive and the most difficult to treat due to there being fewer targeted
medicines available.

A

A

B

Mesenchymal-like

Figure 1.13. (A) MDA-MB-231 epithelial cells expressing mesenchymal-like phenotypes (high
number after 2 days incubation in DMEM at 37 ºC. (B) MDA-MB-231 (ATCC® HTB-26™)
epithelial cells expressing mesenchymal-like phenotypes. Source: ATCC® (2020)
1.8.2

Breast cancer treatment
In the event that cancer develops, the key to successful treatment is early detection.

Prompt early diagnostic and accessible treatment for cancer is critical for survival (Organization,
2017). Cancers are treated with a combination of drugs (angiogenesis inhibitors, modulation of
signaling pathways), chemotherapy (kill or stop proliferation), radiation (kill of stop
proliferation), and/or surgery (removal of tissue infected with cancerous cells)(Arora & Scholar,
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2005; Lebert, Lester, Powell, Seal, & McCarthy, 2018).
Since the dawn on the 21st century, substantial advancements have been made in the
treatment of hormone responsive tumors and gene amplified subtypes, ER+ and HER2+,
respectively, with various types of therapies available including monoclonal-antibody based and
hormonal therapies and small molecule inhibitors of tyrosine kinases for both localized and
metastatic forms of cancer (L. Chen, Linden, Anderson, & Li, 2014; W. Y. Chen et al., 2004;
Ma, Bernstein, Pike, & Ursin, 2006; Verkooijen, Bouchardy, Vinh-Hung, Rapiti, & Hartman,
2009; T. Yoshida et al., 2014). As a result, survival rates of patients diagnosed with the luminal
or amplified subtypes have improved tremendously, particularly for those cancers detected early.
However, the distinct phenotypes, molecular profiles, and lack of viable receptors for targeted
therapy of TNBC result in the ineffectiveness of therapies recommended for other subtypes of
breast cancer.
TNBC present a major challenge for oncologist, as they comprise 10-15% of all breast
cancers diagnosed with limited treatment. This subtype of cancer is more commonly seen in
young and obese women, with a greater prevalence in premenopausal African American women
(Fang et al., 2017; Schäfer et al., 2019). Only systemic treatment options, chemotherapy
combined with standard cytotoxic agents, are available to patients with TNBC.
However, with systemic treatment options, comes great risks. Cytotoxic agents having a
narrow therapeutic window combined with the complexity of their pharmacologic profile results
in a higher risk of experiencing side effects. One problem that may be of subject to scrutiny is
permanent bone marrow damage associated with cancer treatments (Lohrmann, 1984). While
chemotherapy is a principal component of treatment for cancer, the damaged induced on healthy
cells while damaging cancer cells leads to co-morbidity and sometimes mortality (Pearce et al.,
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2017). Most side effects of chemotherapy affect the patient's quality of life, (i.e. appetite loss,
thrombocytopenia, edema, delirium, diarrhea, constipation, fatigue) and the attempts to manage
such side effects have decreased survival rates (Abrams et al., 2012; Blauwhoff-Buskermolen et
al., 2016; Rutten et al., 2016).
1.8.3

Finding alternative treatment
Researchers focus on the genome and their RNA transcripts to develop alternative

therapeutic routines in an effort to decrease the co-morbidity and mortality associate with
treatment of TNBC. A model of TNBC is the MDA-MB-231 cell line, an immortalized human
metastatic cell line isolated at The University of Texas MD Anderson Cancer Center from a
pleural effusion of a patient with invasive ductal carcinoma (Welsh, 2013). MDA-MB-231 cells
are ER-negative, PR-negative, HER2-negative, and express mutated p53.
Additionally, the MDA-MB-231 cell line is mesenchymal in phenotype and have
repressed expression of epithelial (E)-cadherin to facilitate release from the tumor and gain Ncadherin to attach at distal sites. Cadherins are cell adhesion molecules (CAM) that function to
bind cells to one another. Neural (N)-cadherin (CDH2), a cell adhesion molecule than can cause
disassembly and cell migration when inappropriately expressed (Islam, Carey, Wolf, Wheelock,
& Johnson, 1996). CAMs are important in cancer invasion and metastasis. During embryonic
development, organ fibrosis and wound healing a biological process takes place where epithelial
cells convert to a mesenchymal phenotype (Roche, 2018). After such conversion, epithelial cells
lose their cell polarity and cell-cell adhesion, gaining migratory and invasive properties
(fibroblast properties). This process is known as an epithelial-to-mesenchymal transition (EMT),
and the resulting mesenchymal cells are capable of differentiating into a variety of cell types.
Moreover, EMT is not complete in cancer cells, so they express both epithelial and mesenchymal
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genes, making them more aggressive than cells with a complete EMT phenotype (Jolly et al.,
2015). In cancer cells, an increase in N-cadherin, disruption of cell-cell adhesion, expression and
a decrease in C-cadherin are characteristic of EMT.
Research has focused extensively on methods to inhibit or even reverse the EMT process
and induce mesenchymal to epithelial transition (MET) to inhibit tumor metastasis. The
anticancer properties of natural compounds are rapidly gaining interests of many researchers for
this. Varied classes of natural compounds have demonstrated anticancer properties including
marine-based bioactive compounds (Fan et al., 2018; Kim, 2014; Simmons, Andrianasolo,
McPhail, Flatt, & Gerwick, 2005). Carotenoids are associated with numerous health benefits.
One in particular, shown in many epidemiological studies, is the inverse relationship between
various cancers and a high intake of carotenoid containing foods (Astorg, 1997; Martí, Roselló,
& Cebolla-Cornejo, 2016; Ni, Yu, Wang, Zhang, & Shen, 2017; Nishino, Murakoshi, Tokuda, &
Satomi, 2009; Rowles III & Erdman Jr, 2020). However, the exact mechanisms by which the
protection is afforded is still under investigation. Furthermore, in addition to their antioxidant
and provitamin A activity, carotenoids can affect cell growth, regulation, and modulate immune
and gene expression (Mercke Odeberg et al., 2003).
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CHAPTER 2
EXTRACTION OF CRAWFISH AND SHRIMP
ASTAXANTHIN WITH FLAXSEED OIL: EFFECTS ON LIPID
PEROXIDATION AND ASTAXANTHIN DEGRADATION RATES
2.1

Introduction
Louisiana is the nation’s leader in production of crawfish (Procambarus clarkii) and in

shrimp harvesting, whose seasons run from November to July (crawfish) or generally year-round
(shrimp), and is reported to be the world’s second-largest seafood producer by volume
(Delcambre, 2018; Simon-Friedt et al., 2016). The crawfish industry of the South Louisiana,
better known as the crawfish capital of the world, is a multi-million-dollar industry. Louisiana is
also home to an excess of 90% of the crawfish farms in the United States.
As a result of crawfish processing (peeling), crawfish processing byproducts (CB) are
generated containing cephalothorax, abdominal exoskeleton, and viscera, which accounts for
approximately 85% of the whole crawfish (H.-M. Chen & S. P. Meyers, 1982). The processing
byproducts generated from crustacean species are a good source of high-quality bioactive
compounds, i.e. astaxanthin, and there are opportunities to use such processing byproducts to
extract astaxanthin. Astaxanthin can be used as a natural antioxidant ingredient in foods, feeds,
and nutraceutical applications. Astaxanthin, the main pigment found in salmonids and crustacean
species provides the desirable reddish-orange color in many organisms (Additives et al., 2019).
Additionally, the antioxidant activity of astaxanthin is one of its most important
properties. It has been reported that the antioxidant activity of astaxanthin is 10 times higher than
other carotenoids such as zeaxanthin, lutein, canthaxantin, and β-carotene (Miki, 1991; Yuan,
Du, Jin, & Xu, 2013). Several studies have identified astaxanthin as having antioxidant
mechanisms that quench active oxygen species and free radicals in vitro and in vivo (Edge and
others 1997; Palozza and Krinsky 1992; Rengel and others 2000). Due to its antioxidant
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properties, astaxanthin may have a role in the treatment of chronic diseases such as
cardiovascular diseases, cataract development, macular degeneration, and cancer (S. T. Mayne,
1996).
There has been an ever-growing increase in the potential markets for natural antioxidants
in soft drinks, ice cream, desserts, candies, meat products and pet and aquaculture feeds
(Delgado-Vargas and others 2000; Delgado-Vargas and Paredes-Lopez 2003). Although natural
carotenoids only accounted for 24% of the world market in 2014, they are expected to grow an
additional 3.9% in response to increasing consumer demands (Joel, 2015). Astaxanthin was
valued at $512.6 million in 2016, and is predicted to reach $814.1 million by 2022 (Markets,
2017).
Astaxanthin can be extracted from crawfish and shrimp processing byproducts using
solvents or edible oils. H. M. Chen and S. P. Meyers (1982) have extracted astaxanthin from
crawfish processing byproducts using soybean oil. Since, studies have been done to further
increase the biological function and stability of astaxanthin by extracting it with a more health
beneficial edible oil. Astaxanthin has been investigated for its protective effects in flaxseed oil,
which is used as an extraction solvent (Pu & Sathivel, 2011). An established extraction
procedure for extracting astaxanthin from crawfish and shrimp processing byproducts was
developed to microencapsulate flaxseed oil containing astaxanthin (Pu, Bankston, & Sathivel,
2011a, 2011b).
Antioxidant-rich natural astaxanthin dispersed in alpha linolenic acid-rich flaxseed oil
may provide a healthier functional food options for US consumer. Flaxseed oil has high content
of alpha-linolenic acid (ALA) and linoleic acid (LA) which are precursors to long-chain (n-3)
fatty acids such as eicosapentaenoic acid (EPA) and 21 docosahexaenoic acid (DHA),
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respectively (C. Harper, Edwards, DeFilipis, & Jacobson, 2007; Tzang et al., 2009). Both ALA
and LA are considered to be essential fatty acids and studies have shown that ALA can protect
against cardiovascular disease and inflammation (Bloedon & Szapary, 2004).
It is well known that lipid autoxidation of oils mostly depends on the storage temperature
and storage period (Aidos, Lourenco, Van der Padt, Luten, & Boom, 2002; Tan, Man, Selamat,
& Yusoff, 2001). H. M. Chen and S. P. Meyers (1982) have reported that the stability of
astaxanthin is affected by heat, duration of exposure to oxygen, and the intensity of exposure to
light. Therefore, it is important to consider lipid oxidation and degradation rates of flaxseed oil
containing astaxanthin, while simultaneously protecting the function and biological activity of
the astaxanthin.
The utilization of a novel extraction method to eliminate or reduce the previously
mentioned factors that negatively impact the function and stability of lipids and bioactive
compounds, like astaxanthin, is ideal for potentially producing a better product. Ultrasound
assisted extraction (UAE) technologies are of interest for enhancing the extraction of
components from plant and animal tissues, although there is limited information on continuous
UAE. Previously published works on UAE collectively represent several important performance
increases; reduction in extraction time, increased extraction efficiency, and improved extraction
with a reduced extraction temperature (Albu, Joyce, Paniwnyk, Lorimer, & Mason, 2004;
Balachandran, Kentish, Mawson, & Ashokkumar, 2006; Riera et al., 2010; Xia, Shi, & Wan,
2006). The objectives of this study were to extract astaxanthin from crustacean (i.e., crawfish and
shrimp) processing byproducts using flaxseed oil and to study the oxidation rates and the
astaxanthin degradation rates in the flaxseed oil. During the course of this study shrimp
processing byproducts were investigated as a source of astaxanthin. However, since the amount
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of astaxanthin recovered from shrimp processing byproducts was considerably less than that
from crawfish processing byproducts, it was decided to use crawfish processing byproducts for
subsequent studies.
2.2

Materials and Methods
Flaxseed oil was purchased from Whole Foods Market (Baton Rouge, Louisiana). DPPH

(2,2 diphenyl-1-picryl-hydrazyl-hydrate) and potassium iodide were purchased from Sigma
Aldrich (USA), and ascorbic acid was purchased from HiMedia Labs (Mumbai, India. All other
chemicals were obtained commercially and were analytical-grade.
2.2.1

Sample collection
The term “crustacean” used here refers crawfish and shrimp, unless specifically stated

otherwise. Fresh head-on individually quick frozen (IQF) shrimp (Figures 2.1 and 2.2) were
obtained from a local shrimp processor and transported frozen (Figures 2.3) to the laboratory
then stored in a freezer until peeled for further analysis and extraction. For analysis, the shrimp
were peeled to generate shrimp processing byproducts (SB), containing cephalothorax, carapace,
exoskeleton of the abdomen (including pleopods), and viscera. Fresh farmed crawfish, Figure
2.4, were used to obtain crawfish processing byproducts (CB), consisting of the entire
cephalothorax, carapace, exoskeleton of the abdomen, and viscera after parboiling (by producer)
and removal of the tail meat, Figure 2.5, were obtained from a local Louisiana crawfish producer
and processor, and transported to the laboratory frozen on ice. Prior to transportation, CB were
sealed in freezer bags (Figure 2.6) at the processing facility, with minimum headspace, and once
back at the laboratory placed in a freezer at -20 °C until further analysis and astaxanthin
extraction. Prior to ultrasound assisted extraction, the frozen CB (-20 °C) were frozen again at 60 °C, then freeze dried, comminuted using a Magic Bullet® (Capbran Holdings, LLC., Los
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Angeles, CA), sieved and stored in the freezer at -20 °C until future analysis.

Figure 2.1. Vats GOM shrimp at processing facility

Figure 2.2. Shrimp being
emptied into a container for
removal of debris before
peeling process.

Figure 2.3. Thawing of IQF shrimp

Figure 2.4. Crawfish farm
Crowley, LA.

Figure 2.5. Peeling and
sizing crawfish tails.

Figure 2.6. Frozen crawfish
byproducts (peelings).
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2.2.2

Determining proximate, moisture and total extractable astaxanthin of crustacean
processing byproducts

2.2.2.1 Proximate determinations
Three batches of thawed CB or SB were analyzed to determine ash, protein, and fat
contents. Two g samples of CB or SB were samples were sent for protein analysis to the SOIL
sciences lab, where they were analyzed and ashed in a muffle furnace at 550 ºC for 4 h according
to AOAC method 942.05 (AOAC 1995). The protein was calculated by multiplying total
nitrogen content by 6.25. Fat content was determined using a Soxhlet extraction method
according to AOAC method 920.39 (AOAC 1995).
2.2.2.1 Moisture
Moisture content of thawed SB, CB, and freeze-dried CB before and after extraction
procedures was determined using a SMART System 5 microwave moisture analyzer (CEM
Corporation, Matthews, NC), using a rapid microwave drying method specified in AOAC
International procedures for moisture analysis of meat and poultry (AOAC Method 985.14) with
minor modifications, i.e. adjusting time to evaporate moisture from sample to prevent burning
the sample. The weight loss was determined by electronic balance readings before and after
drying.
2.2.2.3 Total extractable astaxanthin in crawfish and shrimp byproducts
The term “astaxanthin” used here refers astaxanthin and all its esters, which have been
identified as the main carotenoids in the exoskeleton of heat-processed crustacean. Three batches
of comminuted crawfish processing byproducts, thawed comminuted shrimp processing
byproducts, freeze dried comminuted crawfish processing byproducts and freeze dried
comminuted shrimp processing byproducts were used for the solvent extraction of astaxanthin
using a method described by Armenta‐López, Guerrero, and Huerta (2002) and H.-M. Chen and
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S. P. Meyers (1982) with slight modification. The crustacean processing byproducts were placed
in petroleum ether-acetone-water (15:75:10 v/v/v) overnight then filtered. The filtrate was
washed with petroleum ether until colorless, and the volume of petroleum ether used was
recorded. The absorbance for petroleum ether layer containing astaxanthin was measured at 468
nm (Hong Kyoon No, 1987) using a GENESYS 20 UV-Vis spectrophotometer (Thermo Fisher
Scientific, Inc., Rochester, NY, USA). The total extractable astaxanthin in 100 g of crustacean
processing byproducts was calculated using equation 2.1 of Kelley and Harmon (1972) and Pu
(2010).
/0123241ℎ64 869:; (=>⁄100 > B8CDE;FG10) =

JKLM × O × PQK
%
R × S UVW

(2.1)

where A = absorbance at maximum wavelength (468 nm) in petroleum ether; V is
%
volume of petroleum ether (mL); W is weight of crustacean processing byproducts (g); X UVW
is

extinction coefficient = 2400 in petroleum ether (H. M. Chen & S. P. Meyers, 1982).
2.2.3

Extraction of astaxanthin from crustacean with flaxseed oil
The effects of pretreatment (freeze-drying, grinding) on the extraction of astaxanthin was

initially investigated for verification purposes (data not shown). Two treatment methods are
used: conventional, frozen (-20 ºC) followed by thawing; and frozen (-20 ºC) then frozen (-60
ºC) followed by subsequent freeze drying. All freeze dried samples were comminuted in a Magic
Bullet® (Capbran Holdings, LLC., Los Angeles, CA) for one minute, then sieved through a 40mesh screen. Retained shells (unpassed through sieve) were reground with additional shells and
subsequently sieved through a 40-mesh screen, followed by sieving through a 30-mesh sieve.
Shells passing through the 40-mesh but not the 30-mesh were used.
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2.2.3.1 Conventional extraction
For conventional extraction, frozen crawfish processing byproducts were thawed or
frozen at -60 ºC then freeze dried and used for extraction frozen shrimp were thawed and peeled
then the shells were used immediately in the extraction process. Previously. Otherwise CB or
SB were kept frozen for later use in extraction of astaxanthin.
Flaxseed oil (FO) containing crawfish astaxanthin (FOCAX) or shrimp astaxanthin
(FOSAX) was prepared using a method of N. M. Sachindra et al. (2005) with slight
modifications as described in Figure 2.7. Crawfish or shrimp processing byproducts (100 g) were
comminuted in a food blender (Magic Bullet®, Capbran Holdings, LLC., Los Angeles, CA),
Figure 2.8, for 5 min, then combined with an equal amount of flaxseed oil (100 g) in a 500 mL
amber Pyrex® bottle. After simple mechanical extraction (heating of comminuted crustacean
processing byproducts/oil mixture 1:1, w/w with constant stirring) for 60 minutes at 60 ºC,
aliquots (Figure 2.9) of the mixtures were centrifuged at 10,000 x g using a centrifuge (Sorvall
RC28S, DuPont, Willmington, DE, USA) for 15 min at 4 °C. This was performed to separate
FOCAX or FOSAX and water phase from the solid phase. The top layer lipid fraction was
separated manually with a separatory funnel (Figure 2.10) and stored at -20 ºC in a sealed
container that limits the transmittance of light at -20 °C for later analysis.
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Peeled crawfish or
whole shrimp
Crawfish minced meat
or peeled shrimp

Crawfish/shrimp (head,
body, carapace)
Comminuted
crawfish/shrimp
byproducts
FO

Extraction of
astaxanthin
Centrifugation
Solid phase

FOCAX/FOSAX
and water
Separatory
funnel

Water

FOCAX/FOSAX

Figure 2.7. Conventional extraction of astaxanthin from crustacean processing byproducts
using flaxseed oil. FOCAX = Flaxseed oil containing crawfish astaxanthin. FOSAX =
Flaxseed oil containing shrimp astaxanthin.

Figure 2.8. Shrimp processing
byproducts.

Figure 2.9. Centrifuge bottle
containing flaxseed oil with astaxanthin
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Figure 2.10. Phase separation using
a separatory funnel

Figure 2.11. Freeze dried crawfish
processing byproducts.

2.2.3.2 Novel extraction: combined ethanol, flaxseed oil, and ultrasound assisted extraction
of astaxanthin from crawfish processing byproducts
The extraction of AX from crawfish processing byproducts followed a similar procedure
as that described in section 2.2.3.1. for crawfish with slight modifications. The crawfish
processing byproducts were collected from Bocage Crawfish, LLC (Figure 2.6). These CB were
frozen and placed on ice then were transported to the laboratory. The frozen CB was frozen at 60 °C before being freeze-dried, comminuted and sieved (40 mesh). The freeze-dried CB
particles were stored in a freezer at -20° C in a 500 mL amber Pyrex bottle. A continuous ultrasonication system was used to provide sonication treatments for releasing AX from the
crustacean processing byproducts. The system consisted of an ultrasonic processor (Model CPX
500, Cole Palmer Instruments, Vernon Hills, IL, USA) with an ultrasonic probe of 13 mm
diameter and an ultrasonic converter for producing sonic waves at a frequency of 20 kHz (Figure
2.10).
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B.
C.
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Ultrasonic processor
Ultrasonic convertor
Processing chamber
Ultrasonic horn
Cooling system
Peristaltic pump with controller
Amber bottle collect extract

C

F

G
Figure 2.12. Ultrasound assisted extraction system used to extract astaxanthin.
The continuous system was established using a double wall stainless steel cylindrical
processing chamber, also called a continuous flow cell (Figure 2.10) which was screwed onto the
threaded portion of the ½ inch Ti alloy (Ti-6Al-4V) ultrasonic horn. Freeze-dried comminuted
CB (25 g) was placed in the flow cell for AX extraction. The mixture of flaxseed oil with 200
mL of ethanol (1:8), was pumped at the rate of 24 mL/min using a peristaltic pump (Master Flex
L/S, Cole Palmer, Vernon Hills, Il, USA) through the collection bottle to the continuous flow
cell was CB were sonicated at 40% amplitude by the ultrasonic processor for 20 minutes.
Ethanol was selected as a continuous co-solvent for extraction due to its GRAS status
(Montanari, Fantozzi, Snyder, & King, 1999). A control sample was prepared by passing only
flaxseed oil or only ethanol through the flow cell containing CB without sonication at a rate of
24 mL/min. Prior to the experiment the continuous flow cell was sanitized using 200 ppm
solution of sodium hypochlorite (Sigma-Aldrich co., St Louis, MO, USA), followed by rinsing
with distilled water to remove residual sanitizer. The temperature of all the samples was
maintained at <25 °C during sonication using a simple chilling method with dry ice. After
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extraction, the crude extracts were vacuum filtered with BUCHI/Whatmann paper #1, 3 times in
a dark room, to remove solid particles. The FO containing AX from ethanol and UAE
(FOCAXUAE) was concentrated by rotary evaporation to remove residual ethanol and stored in
a dark space for immediate analysis. If analyses were to be performed at a later time, samples F
were stored in Eppendorf tubes that restrict the passage of light and stored in the freezer at -20
°C until analysis.
2.2.4

Density, specific gravity, water activity, and moisture content of FO, FOCAX,
FOSAX and flaxseed oil containing crawfish astaxanthin from ethanol and
ultrasound assisted extraction
The density (r) of the FO, FOCAX, FOSAX, and FOCAXUAE was determined in

triplicate using a 10 mL glass-graduated cylinder at 25 °C. The sample was filled to 10 mL, the
mass (g) to volume (mL) ratio determined, and density values (r = m/V) were reported as grams
per milliliter. Specific gravity of the flaxseed oil, FOCAX, FOSAX, and FOCAXUAE samples
was determined in triplicate using a 25 mL glass-measuring cylinder. The net weight of the oil
sample (g) was divided by the net weight of the same volume of water (g) at 25 °C to obtain the
specific gravity. A calibrated water activity (aw) meter (AquaLab Pawkit, Decagon Devices Inc.,
Pullman, WA) was used to measure the water activity of flaxseed oil, FOCAX, FOSAX and
FOCAXUAE at 25°C. The moisture content was measured according to the Karl Fischer titration
method, AOCS Official Method Ca 2e-84, using a Mitsubishi Karl Fischer Moisturemeter
(Mitsubishi Chemical Analytech Co., Ltd., Japan). The sample amount size was 0.3 – 0.35 g for
FO and 0.25 – 0.36 g for FOCAX, FOSAX, FOCAXUAE.
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2.2.5

Measurement of astaxanthin in FOCAX, FOSAX and FOCAXUAE samples.

2.2.5.1 Conventionally extracted astaxanthin concentration
The amount of astaxanthin in the FOCAX and FOSAX was determined
spectrophotometrically at 500 nm wavelength as described by Chen and Meyers (1984). The
astaxanthin extracted from the processing waste was quantified using Equation 2.2. of Kelley
and Harmon (1972) with slight modifications, and reported as mg astaxanthin/100 g flaxseed oil
(FO):
/0123241ℎ64 (=>⁄100> Y%/Z) =

J[\\ ] × PQ^
%
_ × ` × SUab

(2.2)

where A is absorbance at 500 nm; D is dilution factor, d is the cell width (1 cm); S =
%
0.92, specific gravity of flaxseed oil; X UVW
is extinction coefficient = 1827 in flaxseed oil (Pu et

al., 2010); FOAX is flaxseed oil containing crustacean astaxanthin.
2.2.5.2 Combined ethanol, flaxseed oil ultrasound assisted extracted astaxanthin
concentration
Astaxanthin concentration (AXC) in the #UAE oil samples was determined according
to the method of Saito and Regier (1971) with a slight modification. Oil (30 mg) was mixed with
10 ml of petroleum ether and the mixture was allowed to stand for 30 min. The absorbance of oil,
appropriately diluted, was measured at 468 nm using a GENESYS 20 UV-Vis spectrophotometer
(Thermo Fisher Scientific, Inc., Rochester, NY, USA). The concentration (C) of astaxanthin in
the sample was calculated using Equation 2.3:
/0123241ℎ64 (c>⁄> flaxseed oil) =

JKLM × +mnopq mr smnotumv × _unotumv rwxtmy
Q." × zqu{*t mr swp|nq osq_ ({)

where 0.2 is the A468 of 1 μg/ml standard astaxanthin, 10 is the volume of solution in
milliliters, and 1 is the dilution factor of solution.
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(2.3)

2.2.6

Measurement of color for CB, SB, FO, FOCAX, FOSAX, and UAE oils.
The color of CB, SB, FO, FOCAX, FOSAX, and UAE oils were measured in triplicate

using a HunterLab LabScan XE benchtop spectrophotometer (Hunter Associates Laboratory,
INC. Resbon, VA) and was reported in CIELAB color scales (L*, a* and b* values). The
instrument was standardized using the calibrated black and white standards that come with the
instrument. Three grams of flaxseed oil or flaxseed oil with astaxanthin were placed in 1.62 x
1.62 x 0.312 in. polystyrene weighing dish and weighed. Five polystyrene weighing dishes were
stacked together to prevent disturbances for the black base. Chroma, hue angle, and color
difference (DE) values were calculated using Equations (2.4), (2.5) and (2.6), respectively.
Chroma = [a*2 + b*2] 1/2

(2.4)

Hue angle = tan-1 (b*/a*)

(2.5)

∗
∆Xw~
= Ä(Å∗" − Å∗P )" + (2"∗ − 2P∗ )" + (B"∗ − BP∗ )"

(2.6)

(Pagliarini, Vernile, & Peri, 1990)
Where L*, a*, and b* are the degree of lightness to darkness, redness to greenness, and
yellowness to blueness, respectively. Negative Hunter a* values and negative Hunter b* are
converted to positive values for analysis by adding 180º to the arc tangent after conversion to
degrees or 360º to the arc tangent after conversion to degrees, respectively, for calculating the
proper hue based on the appropriate quadrant (McLellan, Lind, & Kime, 1995).
2.2.7

Measurement of Lipid Oxidation.

2.2.7.1 Peroxide value
Measurement of peroxide values (POV), lipid hydroperoxides, in FO, FOCAX, FOSAX
and FOCAXUAE were determined by two titrimetric methods. For FO, FOCAX, and FOSAX
samples, the POV were determined as described by Shantha and Decker (1994) using the
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International Dairy Federation (IDF) standard method 74A:1991 with slight modifications. POV
measures the transient products of oxidation when peroxides form and breakdown, like
hydroperoxides formed during the initial stages of lipid oxidation, with high values translating to
the instability of an oil during storage. To prepare the iron (II) chloride solution, 0.4 g barium
chloride dihydrate was dissolved in 50 mL water. The solution was added slowly while stirring
to an iron (II) sulfate solution (0.5 g FeSO4*7H2O dissolved in 50mL water). Then two milliliters
of 10N hydrochloric acid was added and the barium sulfate precipitate was filtered off to give a
clear iron (II) solution, which was stored in the dark in brown bottles. Thirty grams of
ammonium thiocyanate was dissolved in distilled water in an Erlenmeyer flask and brought to
volume (100 mL). Peroxide values were calculated as follows:
Ñ9DE36;9 Ö2:F9 =

(Üá & Üà ) × p

(2.7)

ââ.äã×p\ ×"

Where /s = absorbance of the sample at 500 nm; /~ = absorbance of the blank
containing all the reagents except the sample at 500 nm; = = 41.52 (Shantha & Decker, 1994).
The second titrimetric method for determining peroxide value is ideal for small-scale
samples. For the UAE samples, the POV was determined in triplicate in accordance with a
method of Crowe and White (2001) for small oil samples with slight modifications. An acetic
acid-chloroform solution (3:2, v/v) was prepared. A saturated potassium iodide (KI) solution was
also prepared by dissolving excess KI in previously boiled distilled water (about 25.0-gram KI in
15.0 mL water). The solution was stored in the dark when not in use. A 0.001 N sodium
thiosulfate (Na2S2O3) solution was prepared by diluting a 0.1 N Na2S2O3 stock (4.962 g Na2S2O
dissolved in distilled water, and brought to 200 mL) 100-fold. Then 50 µL iron (II) solution was
added and mixed for 3-4 s. After 5 min incubation at room temperature, the absorbance of the
sample (FOCAXUAE) was measured at 500 nm against a blank that contained all reagents but
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the sample by using the spectrophotometer. This was conducted under dim light and completed
within 10 minutes. The POV, expressed as millimoles of peroxide (==E: %""& ) per kilogram of
sample, was calculated using the following formula:
Ñ9DE36;9 Ö2:F9 =

(`&å)×ç×PQQQ

(2.8)

pwss mr swp|nq,{

2.2.7.2 Thiobarbituric acid-reactive substances (TBARS) analysis of FO, FOCAX, FOSAX,
and UAE extractions
TBARS content of FO, FOCAX, FOSAX, and all FOCAXUAE (50UAE0, 25UAE, and
10UAE) sample were measured using methods described by Mei, McClements, Wu, and Decker
(1998) and Lemon (1975) with modifications. TBA (thiobarbituric acid) solutions were prepared
by mixing 15 g of trichloroacetic acid, 0.375 g of TBA reagent, 1.76 mL of 12 N HCl, and 82.9
mL of distilled H2O. Every 100 mL of TBA solution was mixed with 3 mL of 2% butylated
hydroxytoluene in ethanol. A 0.1 g sample of oil was added to 0.4 ml of water then combined
with 2.5 ml of TBA solution in a 15 ml capped glass tube vortexed and placed in boiling water
(95-100 °C) for 15 min. After cooling to room temperature, the mixture was centrifuged at 1163
× g for 25 min using a benchtop centrifuge (Compact II Centrifuge, Becton-Dickinson,
Rutherford, New Jersey, USA) and absorbance was measured at 532 nm. TBA values were
calculated from a standard curve prepared using TEP (1,1,3,3-tetraethoxypropane) standard and
expressed as mg malondialdehyde (MDA) kg-1oil.
2.2.8

Studies on oxidative stability of FO, FOCAX, FOSAX, and FOCAXUAE
A modified method of Ragnarsson and Labuza (1977) was employed to evaluate the

ability of astaxanthin as an antioxidant to protect flaxseed oil from detrimental effects of elevated
temperature over time. One hundred twenty-five mL amber Erlenmeyer flasks containing 50±2 g
of oil samples each was used. The flasks were placed in a water bath at 65 °C to model
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accelerated shelf life (ASL), while other amber flasks containing oil samples, were not exposed
to heat, and placed at room temperature 25±0.2 °C. An oil sample was taken from the amber
flasks using a pipette every hour from 0 to 4 hours for POV. A plot of POV versus time was
constructed for 65 °C. The resultant straight line yielded the of oxidation rate (=Xè %""& ·kg oil1

·h-1) at 65 °C.

2.2.9

Free fatty acids of FO, FOCAX, FOSAX, and FOCAXUAE
Free fatty acid (FFA) content was determined in triplicate for each sample according to a

titrimetric method of Ke, Woyewoda, Regier, and Ackman (1976) with slight modification. One
g samples of oil before and after extracting AX was placed using a dropper and weighed (±0.005
g) on an analytical benchtop scale in an Erlenmeyer flask and 75 mL of ternary solvents
(Chloroform, Methanol, Isopropyl Alcohol; 2:1:2) were added, followed by 4 drops of metacresol purple (MCP) indicator solution. As the sample was being mixed on a stir plate, the FFAs
were titrated to the purple endpoint with 0.05 N NaOH using a burette. The blank was ternary
solvents and MCP. The percentage of FFA was expressed as oleic acid equivalents using the
equation described by Ke et al. (1976).
YY/ 20 % E:96G =

(ê&å)×P.ãP

(2.9)

`

Where T and B are the volume (ml) of 0.05 N NaOH used to titrate the sample and the
blank, respectively, and S is the weight (g) of sample.
2.2.10 Vitamin C equivalent antioxidant capacity (VCEAC) of FO, FOCAX, FOSAX, and
FOCAXUAE samples in scavenging DPPH (2,2 diphenyl-1-picryl-hydrazyl-hydrate)
radical, a spectrophotometric assay
The radical-scavenging activity of ethanolic ultrasound-assisted extracted AX in FO was
assayed following a method described by Rao, Sarada, and Ravishankar (2007) with some
modifications. A stable free radical, DPPH (2, 2-diphenyl-1-picryl-hydrazyl), was used to
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evaluate the free radical scavenging capability of FO, FOCAX, FOSAX, and FOCAXUAE
samples. DPPH reagent (2.36 mg) was dissolved in 100 mL of ethanol in an Erlenmeyer flask, in
the dark, with 10 min sonication to ensure complete solubilization in the dark. The ethanolic
DPPH solution (60 µM) was kept in the dark. One mL of the DPPH solution added to 3 mL of
FO, FOCAX, FOSAX, and FOCAXUAE extracts. The percent of DPPH radical-scavenging
activity, or inhibition, was calculated as:
ëÑÑ' 0G2Ö94>64> 2G16Ö618 (%) =

Üaíìîïíñ &(Üáóbòñô & Üáóbòñô àñóìö )
Üxmvtymn

× 100

(2.10)

where Acontrol, Asample, and Asample blank are the absorbance of the DPPH solution (1.0 mL:
60 uM) plus ethanol, astaxanthin solution with DPPH (different concentration) and astaxanthin
solution containing ethanol without DPPH, respectively. The absorbance measurements were
taken at 517 nm.
2.2.11 Preparation of standard curve for the absorbance of DPPH against
A Vitamin C (ascorbic acid) calibration curve that relates the concentration of vitamin C
and the amount of absorbance reduction caused by vitamin C were obtained using the DPPH
assay. In order to express DPPH radical scavenging results as mg Vitamin C L-1 oil a calibration
curve was prepared using 0.1 mL ethanolic solutions of ascorbic acid in the range 0–113.5 mM
or 20 mg. The linearity was found up to 113.5 mM concentration of ascorbic acid and a line was
calculated (Figure 2.11). The absorbance at 0-30 minutes of incubation with DPPH radical
(2.4 mL) was recorded. The absorbance reduction was measured at 517 nm for the astaxanthin
extracts (FO, FOSAX, FOCAX, and FOCAXUAE against the various concentrations DPPH
radical to then determine the VCEAC equivalent of each extract.
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Figure 2.13. Calibration curve using ascorbic acid.
Calibration curves of absorbance reduction of DPPH radicals versus vitamin C
concentration were generated. The decreasing absorbances at 517 nm for DPPH radical
scavenging activity by FO, FOCAX, FOSAX, and FOCAXUAE were measured at various
concentrations. The results were converted into VCEAC (Vitamin C equivalent antioxidant
capacity) using the vitamin C calibration curve. The scavenging activities of tested compounds
against DPPH radicals were calculated as VCEAC in mg/100 ml.
Ascorbic acid was dissolved in ethanol to make 0 – 20 mg 100 ml-1 concentrations and
plotted vs. absorbance at 517 nm. Samples were prepared in triplicate.
2.2.12 Statistical analysis
Mean values and standard deviations of triplicate reproducible analyses are reported. The
statistical significance of observed differences among treatment means was evaluated by analysis
of variance (ANOVA) was carried out to determine the difference among treatment means with
SAS software Version 9.4 (SAS Institute Inc., Cary, NC) using a post hoc Tukey's studentized
range test (SAS, 2013) at a significance level of 0.05.
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2.3

Results and Discussion

2.3.1 Proximate compositions and total extractable astaxanthin of crustacean processing
byproducts.
Moisture content (wet weight basis, wwb) of crawfish and shrimp and crawfish
processing byproducts was 53.69±0.1% and 74.82±0.02%, respectively. The moisture content
(dry byproducts, db) of crawfish and shrimp processing byproducts was 2.92±0.01% and
3.19±0.03, respectively. The moisture content (wwb) for thawed shrimp processing byproducts is
higher, but for thawed crawfish processing byproducts is similar to that reported in previous
works by Pu (2010), 62.82% and 54.68%, respectively. Furthermore, the moisture content of the
produced solid waste after conventional extraction of astaxanthin from crawfish and shrimp, was
57.69% and 60.04 %, respectively, while after UAE extraction of AX from crawfish processing
byproducts their moisture content was 46.31 %. The values from conventionally extracted
crustacean byproducts were higher than those reported by Pu (2010) for shrimp, 62.82 %, and
crawfish, 54.68 %.
Ash, fat, and protein contents (db) of crawfish processing byproducts before extraction
were, 40.76±0.05 %, 6.6±0.06 %, and 37.93±0.2 %, respectively (Table 2.1). The ash content
was within 5 % of values reported by authors in other works, 42.97% (Pu, 2010) and 35.7 %
(Meyers & Bligh, 1981). However, the fat content was very close to that other authors reported,
6.7 % (Meyers & Bligh, 1981). The total ash, fat, and protein contents for the shrimp processing
byproducts accounts for 88.29 %, resulting in the remaining 14.71 % possibly being chitin.
Ash, fat, and protein contents (db) of shrimp processing byproducts before extraction
were 18.14±0.68 %, 7.93±0.33 %, and 57.1±0.57 %, respectively (Table 2.1). Previously
reported ash, fat, and protein content values were, 17.41%, 7.22%, 60.2%, respectively, and
22.2%, 22.7%, and 51.3%, respectively (Lee and others, 1999). The proximate composition of
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shrimp processing byproducts varies, depending on their age, diets, species or native habitats,
which depend on the season (N. M. Sachindra et al., 2007; Yanar, Çelik, & Yanar, 2004). The
total ash, fat, and protein contents for the shrimp processing byproducts accounts for 83.17 %,
resulting in the remaining 16.83 % potentially being chitin.
Astaxanthin being lipophilic, is solubilized in lipids. Therefore, the quantification of
astaxanthin can be approached from a comparable assessment to extracting lipids with solvents.
Likewise, extraction was performed to measure the total amount of extractable astaxanthin in the
crawfish (thawed) processing byproducts, shrimp (thawed) processing byproducts,
crawfish (freeze dried) processing byproducts, and shrimp (freeze dried) processing byproducts.
The result was 8.53±0.15 mg 100 g−1 waste, 13.83±0.31 mg 100 g−1 waste, 10.21±0.04
mg 100 g−1, and 18.68±0.04 mg 100 g−1 freeze-dried waste, respectively. The total AX content
for wet but not freeze-dried crawfish was slightly lower than that extracted using the same
solvents, petroleum ether-acetone-water mixture, to extract astaxanthin from crawfish waste,
15.3 mg of astaxanthin 100 g-1 of crawfish processing byproducts (Meyers & Bligh, 1981). After
comparing the total extractable astaxanthin data, it was determined that crawfish processing
byproducts would be used for all subsequent studies.
2.3.2 Physicochemical characteristics and astaxanthin content of FO, FOCAX, FOSAX,
and FOCAXUAE
The FO, FOCAX, FOSAX, and FOCAXUAE densities (g/mL) were 0.91±0.00,
0.92±0.07, 0.92±0.02 and 0.91±0.03, respectively (see Table 2.2), which was a little higher than
values reported by Sathivel (2005) for red salmon oil (0.9 g/mL) and pink salmon oil (0.81
g/mL). Specific gravities of the FO, FOCAX, FOSAX, and FOCAXUAE were 0.92±0.00 at
room temperature. The moisture contents of the FO, FOCAX, and FOSAX were 0.15±0.00%,
0.17±0.03%, 0.17±0.05%, while in FOCAXUAE the moisture content was 0.15±0.03%. The
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water activity of FO (0.51±0.0), FOCAX (0.52±0.0), FOSAX (0.52±0.0), and UAEAX
(0.51±0.7) was slightly lower than other values reported by Sathivel (2005) for red salmon oil
(0.57) and pink salmon oil (0.53). Moisture in oil increases the FFA content of the oil by lipid
hydrolysis reactions (Bhattacharya and others 2008). Water contributes to the hydrolysis of oil
during various handling and processing steps, which generate free fatty acids and glycerol
products that decrease the oxidative stability of oils (Bhattacharya, Sajilata, Tiwari, & Singhal,
2008; Choo, Birch, & Dufour, 2007b). FFA content is an intrinsic factor that impacts oxidative
stability and shelf-life of oils. Therefore, it is most desired to have an oil with a low aw value.
For conventional extraction using FO, the astaxanthin concentration (AXC) in FOCAX
(1:1, CB: oil), FOSAX (1:1, SB: oil) and the FOCAXUAE (1:1:8, 25g CB: 25g oil: 200g
ethanol) per gram of flaxseed oil were, 0.054 mg g−1, 0.092 mg g−1 , and 1.9 mg g−1, respectively
(Table 2.3), which are similar to values previously reported in the literature for shrimp
processing byproducts, 0.049 mg g-1 dry waste by De Holanda and Netto (2006) and (De
Holanda & Netto, 2006; Handayani, Indraswati, & Ismadji, 2008) and crawfish processing
byproducts (Meyers & Bligh, 1981). Conversely, the values were greater than those reported by
Pu (2010) for crawfish and shrimp, 0.0884 mg g−1 wet CB and 0.0647 mg g−1 wet SB,
respectively. The conventionally extraction technique used here was similar to that of Pu (2010)
with slight modification. Key differences to highlight include pre-treatments applied like
comminuting and freeze-drying. In a previous investigation, De Holanda and Netto (2006) used
an enzymatic method to extract astaxanthin from shrimp (Xiphopenaeus kroyeri) processing
byproducts using soy oil and extracted 4.90 mg astaxanthin 100 g−1 processing byproducts. The
amount of conventionally extracted astaxanthin in both FOCAX and FOSAX was greater than
that in other vegetable oils such as sunflower oil, groundnut oil, coconut oil, and rice bran
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oil obtained by N. Sachindra and Mahendrakar (2005). Meyers and Bligh (1981) reported a 10fold increase in astaxanthin concentration with vacuumed dried shrimp processing byproducts
(0.100 mg/g) compared to heat dried shrimp processing byproducts (0.010 mg/g). H.-M. Chen
and S. P. Meyers (1982) compared the astaxanthin recovery between heat processed CB (0.1615
mg/g) and unprocessed (not heat processed) CB (0.0878 mg/g) using standard organic solvents
for extraction. They found that pretreatment with a sonifier and particle size reduction
contributed to the increase in recovery. Still, the amount of conventionally extracted astaxanthin
from crawfish (FOCAX) and FOCAXUAE in this study was greater than that obtained by Chen
and Meyers.
The amount of astaxanthin recovered by UAE ratios were 0.8 mg g−1 lipid, 1.9 mg 1 g−1
lipid, and 0.9 mg g−1 lipid, for ratios CB:FO to ethanol (E) 1:1:4 (A), 1:1:8 (B), and 1:1:20 (C),
respectively. While the amount of astaxanthin recovered by conventional extraction were, 0.054
mg g−1 FO (FOSAX), 0.092 mg g−1 FO (FOCAX). Both CFO, 0.1 mg g−1, or NFO, 0.2 mg. g−1,
alone yielded lower extractions of AX than did the combination of the two within the closed
system. Although, the extraction yields were still greater than the conventional method of
extraction with regard to the amount flaxseed oil and crustacean byproducts used.
Numerous studies have revealed that the yield of astaxanthin depends upon many factors;
such as the extraction methods, the solvents or media used for extraction, and other factors such
as particle size of the waste and ratio of waste to oil used for extracting astaxanthin from
crustacean processing byproducts (Praveenkumar, Lee, Lee, & Oh, 2015; N. Sachindra et al.,
2006). However, for UAE, ethanol (E) was combined with the flaxseed oil to extract astaxanthin,
which explains why FOCAXUAE had a higher concentration of astaxanthin than FOCAX and
FOSAX. E was chosen as a co-solvent for the ultrasound-assisted extraction of AX, and was
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previously shown to be the best solvent for extracting AX (Bi, Tian, Zhou, & Row, 2010).
Ethanol, a very polar short chain alcohol lacks FDA regulatory problems, unlike many other
solvents. It is the least toxic of the alcohols and is suitable for use in industry and consumer
products. Previous studies also give supporting data for greater extraction yields of astaxanthin
obtained when organic solvents were used (Ali-Nehari, Kim, Lee, Lee, & Chun, 2012; Reyes,
Mendiola, Ibanez, & del Valle, 2014). The differences in extractions of AX could be attributed to
the additional reduction in the moisture content of the CB by E. Polar solvents (i.e., ethanol) will
help remove the water in the solid matrix making the less polar pigment (i.e., astaxanthin) more
available for extraction in non-polar solvents (N. Sachindra et al., 2006).
Table 2.1. Proximate compositions and AX content of CB, SB, freeze-dried CB, and freeze-dried
SB.
Astaxanthin
% Moisture % Moisture
Treatment (mg g-100
Ash %
Fat %
Protein %
(wwb)
(db)
byproducts)
SSBW 8.53±0.15A 74.82±0.02A
18.14±0.68A 7.93±0.22A 57.1±0.57A
SCBW 13.83±0.31B 53.69±0.01A
40.76±0.05B 6.6±0.06A 37.93±0.2B
3.19±0.02A
SFDSB 10.21±0.04 D
2.92±0.01A
SFDCB 18.68±0.04C
Note: Values are means ± SD of triplicate determinations. SSBW = Solvent extraction of 100 g
thawed shrimp processing byproducts; SCBW = Solvent extraction of 100 g thawed crawfish
processing byproducts; SFDSB = Solvent extraction of 100 g freeze dried shrimp processing
byproducts SFDCB = Solvent extraction of 100 g freeze dried crawfish processing byproducts.1

1

For SFDSB and SFDCB, the ash, fat, and protein data are not shown because the determinates would not differ.
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Table 2.2. Physicochemical properties of FO, FOCAX, FOSAX, and FOCAXUAE.
FO

FOSAX

FOCAX

FOCAXUAE

Density
0.91±0.00 A
0.92±0.07 A
0.92±0.02 A
0.91±0.03 A
S.G.
0.92±0.00 A
0.92±0.00 A
0.92±0.00 A
0.92±0.00 A
Moisture %
0.15±0.00 A
0.17±0.03 B
0.17±0.05 B
0.15±0.03 A
Note: Values are means ± SD triplicate determinations. Values not containing the same letters
in the same row are significantly different (P<0.05). FO = Flaxseed oil; FOCAX = Flaxseed oil
containing crawfish astaxanthin from conventional extraction; FOSAX = Flaxseed oil
containing shrimp astaxanthin from conventional extraction; FOCAXUAE = Flaxseed Oil
Containing Crawfish Astaxanthin From Ethanol and Ultrasound Assisted Extraction. S.G. =
specific gravity.
Table 2.3. AXC, POV and TBARS of FO, FOSAX, FOCAX, 10UAE, 25UAE and 50UAE
with FOAX, NFO and CFO.
Treatment AXC (mg g-1 oil) POV (mmol O2 . kg-1)
FOSAX*
FOCAX*
UTCB**
UTO (FO)
50UAE**
25UAE**
10UAE**
NFO**
CFO**

0.054±0.403E
0.092±0.912C
2.1±1.34e-4D
NA
0.8±1.86e-5B
1.9±2.44e-4A
0.9±3.41e-5B
0.2±1.74e-6C
0.1±9.58e-6C

1.84±0.05 A
1.64±0.09 A
1.35±0.83B
1.27±0.55B
1.75±1.61C
1.59±0.33A
1.35±0.60B
2.49±1.04B
4.21±1.11B

TBARS (mg MDA. kg-1)

FFA

1.49±0.02 F
1.39±0.07 E
2.38±0.01A
2.09±0.04A
1.95±0.00C
1.77±0.55B
1.55±0.03D
2.09±0.03A
2.11±0.03E

2.85±0.01 D
2.17±0.03 B
2.13±0.06 B
1.57±0.01 C
2.01±0.01 A
1.96±0.04 A
1.94±0.11 A
2.48±0.94 C

Values are means of triplicate determinations. A-E Means ± SD containing the same letters in the
same column are not significantly different (P<0.05). AXC = Astaxanthin concentration. POV =
Peroxide value after the 60-minute conventional extraction time or 20-minute UAE time;
TBARS = Thiobarbituric acid reactive substances. FFA = Free fatty acids. FOCAX = Flaxseed
oil containing crawfish astaxanthin from conventional extraction; FOSAX = Flaxseed oil
containing shrimp astaxanthin from conventional extraction; FO = Flaxseed oil; CB = crawfish
processing byproducts; UAE = ultrasound-assisted extraction with ethanol; 50UAE = 50 g CB
with 50 g FO, 25UAE = 25 g CB with 25 g FO, 10UAE = 10 g CB with 10 g FO; UTCB = NonUAE oil with ethanol 25 g CB; UTO = Non-UAE oil with ethanol without CB; NFO = EtOH
only with 25 g CB; CFO = Just FO only with 25 g CB; For NFO, 3g of flaxseed oil used for
quantitative measurement of AX and oxidative stability. * denotes POV determined by IDF
74A:1991 method. ** denotes POV determined by method of Crowe and White (2001).
2.3.3 Color evaluation of FO, FOCAX, FOSAX, and FOCAXUAE
All color values (L*, a*, b*, chroma, hue angle, DE) of CB and SB before and after
extraction, as well as FO, FOCAX, FOSAX and FOCAXUAE are shown in Table 2.4. The L*
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value is a measure of the lightness (0-100), while a* and b* values are the measurement of
redness (more +) and yellowness (more +), respectively. The L* values of all the oil-based
samples are slightly darker (FOCAX = 45.74; FOSAX = 48.57; 10UAE = 31.17; 25UAE =
39.39; 50UAE = 41.87) in color than FO, 49.02 and HFO = 52.32. Conversely, the a* values of
all the oil-based samples were determined to have more redness (FOCAX = 11.34; FOSAX =
8.84; 10UAE = 33.61; 25UAE = 39.76; 50UAE = 30.89) in color than FO, 1.88. The b* values
of all the oil-based samples were determined to have less yellowness (FOCAX = 64.68; FOSAX
= 73.08; 10UAE = 60.07; 25UAE = 65.35; 50UAE = 53.98) than FO, 77.34. As it relates to
color measurements for the crustacean processing byproducts, the color values of L*, a* and b*
are representative of the extraction processes. The SB before extraction had L*, a* and b* values
of, 60.71, 0.15 and 5.22, respectively. CB had L*, a* and b* values of, 53.68, 57.86, and 13.88,
respectively. Conversely, the SB after extraction L*, a* and b* values were, 58.39, 20.09 and
45.76, respectively, and after extraction, the CB L*, a* and b* values were, 48.47, 5.34, and
14.2, respectively. There was a decrease in redness of CB. This may be attributed to the removal
of astaxanthin from solid material. Chroma is a measurement of the vividness of color (higher
values indicate a more vivid color). The chroma values for FO, FOCAX, FOSAX, and 25UAE
were, 77.35, 73.71, 73.62, and 76.49, respectively (Table 2.3). Hue angle is defined as a color
wheel with red-purple at an angle 0º and yellow at 90º (Ergüneş & Tarhan, 2006) The hue angle
values for FO, FOCAX, FOSAX, and 25UAE were, 88.61, 81.15, 83.1, and 58.68, respectively
(Table 2.3). Of the UAE samples, 25UAE had higher chroma value than 50UAE and 10UAE,
indicating that 25UAE had a more vivid color than 50UAE and 10UAE.

70

The greater the color difference amongst the oil samples correlated with the greater
astaxanthin yield. FOCAX and FOSAX (conventional extraction) and, FO. The FOCAXUAE
oils were referenced to FO within treatments for determining the color differences.
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Table 2.4 – Color in terms of L*, a*, b*, Chroma, Hue, and color difference of FOSAX, FOCAX, HFO and FO.
Sample

L*

a*

b*

C*

h*

FO
HFO
FOAX
FOSAX
FOCAX

49.03±0.15A
52.32±0.25B
29.78±0.94 E
48.57±0.15A
45.74±0.15 A

1.88±0.2 C
1.40±1.16 B
47.07±0.94D
8.85±0.15A
11.34±0.56A

77.34±0.36 A
62.82±0.67 B
60.00±0.94 B
A
73.08±0.94
B
64.68±0.19

77.35±0.94A
62.84±0.49A
76.26±0.12C
A
73.62±0.85
A
73.71±0.65

88.61±1.94A
88.72±0.75A
51.89±0.94A
A
83.1±0.79
A
81.15±2.01

50UAE

41.87±0.94 A

30.89±1.39

D

53.98±0.07

B

62.19±0.92

25UAE

39.39±0.13D

39.76±1.43

D

65.35±1.32

B

76.49±1.53

10UAE

31.17±0.1.47D

33.61±1.43

D

60.07±1.76

B

68.83±1.25

SB

60.71±0.22 C

0.15±0.02

SBA

58.39±1.59C

20.09±1.23

B
C.

5.22±0.99

C

45.76±1.03

C

5.22±0.67

B

60.22±1.63

B

37.92±0.71

A

58.68±1.15

B

40.88±0.36

B

60.77±1.31

B

40.29±0.23

C

49.98±0.87

Color difference
∗
(Δ"#$
)
NA
2.51±0.14 A
NA
A
8.18±0.05
A
10.98±0.09

D

A

88.35±3.19

A

66.30±0.67

B,
B
B

NA
B

45.24±0.82

E
D
C
C
CB
53.68±1.43B
NA
57.86±2.67
13.88±0.99
59.5±1.75
13.49±0.91
D
E
B
B
CBA
48.47±1.55B
5.34±0.81
14.2±1.63
15.17±0.83
69.39±0.14
52.79±0.04
Values are means of three determinations. A-E Means within same column bearing different letters are significantly different
(p<0.05). FOSAX = Flaxseed oil containing astaxanthin heated at 65º C for 1 h; FOCAX = Flaxseed oil containing
astaxanthin heated at 65º C for 1 h; FOCAXUAE = Flaxseed oil containing crawfish astaxanthin from ultrasound assisted
extraction heated at 65º C for 1 h; HFO = Flaxseed oil heated at 65º C for 1 h; FO = Flaxseed oil; SB = shrimp processing
byproducts (wet) before extraction; CB = crawfish processing byproducts (wet) before extraction; SBA = shrimp
processing byproducts (wet) after extraction; CBA = crawfish processing byproducts (wet) after extraction; 50UAE = 50
g CB with 50 g FO, 25UAE = 25 g CB with 25 g FO, 10UAE = 10 g CB with 10 g FO L* = lightness ; a* = redness; b* =
yellowness; C* = chroma or vividness; h* = hue angle.
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The changes in the lightness (L*), redness (a* value) and yellowness (b* value) for the
extraction methods considered are shown in Figures 2.12, 2.13, and 2.14. Lightness does not
seem to be affected by extraction conditions; slightly different L* values were recorded for the
oils utilized for UAE and the oils utilized for conventional extraction. The most significant
differences are observed in a* values, which are related to the tonality of color, possibly an
increase in AX content of the oil, release of AX from the carotenoprotein matrix, or removal of
AX from the shell matrix. 25UAE had higher redness (a* = 39.76) after extraction than did CFO
(a* = 0.26). CFO (control, flaxseed oil only with ultrasound assisted extraction using 25 grams
of crawfish processing byproducts) was lighter and less yellow (L* = 48.45 and b* = 37.15) in
color than 50UAE, 25UAE, and 10UAE (L* = 43.31, 39.38, and 43.31 and b* = 53.98, 65.35,
60.07, respectively). The study demonstrated that the closed ultrasound assisted extraction
system combining ethanol with flaxseed oil could be an effective method to efficiently improve
the extraction of astaxanthin using only 25 g of flaxseed oil and 25 g crawfish processing
byproducts, thus increasing yield.
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Figure 2.14. L* value, measurement of lightness to darkness in terms of CIELAB color
scale. L* means ± SD values of triplicate determinations. A-C Means ± SD not containing a
letter in common are significantly different (p=0.05). UTO = flaxseed oil only pumped
through system without CB and no UAE; NFO = ethanol only pumped through system
with CB and no UAE; 10UAE = 10 g flaxseed oil containing AX post UAE of 10 g CB;
25UAE = 25 g flaxseed oil containing AX post UAE of 25 g CB; 50UAE = 50 g flaxseed
oil containing AX post UAE of 50 g CB; 10 CB = 10 g crawfish processing byproducts
(wet) after extraction; 25 CB = 25 g crawfish processing byproducts (wet) after extraction;
50 CB = 50 g crawfish processing byproducts (wet) after extraction.

Figure 2.15. a* value, measurement of red to green in terms of CIELAB color scale. A*
means ± SD values of triplicate determinations. A-E Means ± SD not containing a letter in
common are significantly different (p=0.05). UTO = flaxseed oil only pumped through
system without CB and no UAE; NFO = ethanol only pumped through system with CB
and no UAE; CFO = flaxseed oil without ethanol for UAE; 10UAE = 10 g flaxseed oil
containing AX post UAE of 10 g CB; 25UAE = 25 g flaxseed oil containing AX post UAE
of 25 g CB; 50UAE = 50 g flaxseed oil containing AX post UAE of 50 g CB; 10 CB = 10
g crawfish processing byproducts (wet) after extraction; 25 CB = 25 g crawfish processing
byproducts (wet) after extraction; 50 CB = 50 g crawfish processing byproducts (wet) after
extraction.
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Figure 2.16. b* value, measurement of yellow to blue in terms of CIELAB color scale. B*
means ± SD values of triplicate determinations. A-E Means ± SD not containing a letter in
common are significantly different (p=0.05). UTO = flaxseed oil only pumped through
system without CB and no UAE; NFO = ethanol only pumped through system with CB
and no UAE; CFO = flaxseed oil without ethanol for UAE; 10UAE = 10 g flaxseed oil
containing AX post UAE of 10 g CB; 25UAE = 25 g flaxseed oil containing AX post UAE
of 25 g CB; 50UAE = 50 g flaxseed oil containing AX post UAE of 50 g CB; 10 CB = 10
g crawfish processing byproducts (wet) after extraction; 25 CB = 25 g crawfish processing
byproducts (wet) after extraction; 50 CB = 50 g crawfish processing byproducts (wet) after
extraction.
2.3.4. Oxidative stability and quality of FO, FOSAX, FOCAX, and FOCAXUAE.
The quality of the oil samples was evaluated by color, water content, content of free fatty
acids (FFA), peroxide value (POV), thiobarbituric acid reactive substances (TBARS), and
antioxidant capacities of FO, FOSAX, FOCAX, and FOCAXUAE. Following the extraction
procedures, samples of the oils were taken for assessment of oxidative stability as a quality
parameter. The peroxide value measures the degree of oxidation in fats and oils and measures the
amount of total peroxides as a product of primary oil oxidation (Farhoosh & Moosavi, 2009).
POV is a representation of the quantity of active oxygen (in mg) within 1 g of lipid that could
oxidize potassium iodide releasing iodine. In the conventional extraction of AX from SB and
CB, the POV of FO, FOCAX, and FOSAX were 1.27, 1.64 and 1.84 mmol O2. Kg-1,
respectively. The POV of 50UAE, 25UAE, and 10UAE were 1.75, 1.59, and 1.35 mmol O2 . kg-1
of oil. These values were lower than that of CFO, 4.27 mmol O2 .kg oil-1. The POV of FO
(UTO), 0.64 mmol O2 .kg oil-1, was similar to that reported by Symoniuk, Ratusz, and Krygier
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(2016), who measured POV ranging from 0.78 – 1.11 mmol O2 .kg oil-1. Initial results for FO,
FOCAX, FOSAX, and FOCAXUAE showed that the oils used for extraction developed a small
amount of peroxides. Although oils containing AX underwent oxidation during both
conventional and novel extraction methods, extraction using the latter method resulted in a lower
POV value. Additionally, peroxide values are used as a measurement of rancidity of oils which
occur by auto oxidation. Furthermore, since the carotenoid portion may also be degraded during
lipid peroxidation processes, the measurement of POV in the oils containing carotenoids may
also provide information about color stability (Hornero-Méndez, Pérez-Gálvez, & MínguezMosquera, 2001). Greater exposure to oxygen in conventional extraction processes yielded more
than the minimal oxidation created by the low exposure to oxygen in the novel extraction
method. Thus, the oil obtained by UAE showed greater stability compared to the oil extracted via
the conventional method. TBARS of 50UAE, 25UAE, and 10UAE were 1.95, 1.77, and 1.55 mg
MDA .kg oil-1, respectively were lower than CFO, 2.11 mg MDA .kg oil-1 (see Table 2.3). After
extraction of AX with previously mentioned methods, UAE using 25 g of CB and 25 g flaxseed
oil (25UAE) was determined to be the best quantities for the apparatus to effectively extract
astaxanthin efficiently and with minimal oxidative impact. Even though the lowest lipid
oxidation, POV and TBARS, were observed with 10UAE, it was not selected for future work due
to its astaxanthin yield being lower than that of 25UAE. Lower POV and TBARS values were
also seen with 25UAE than with FO and conventionally extracted FOSAX.
In addition to UAE reducing the potential degradative effects of using an increased
temperature for extracting AX, it also had a greater yield of AX from CB. This may also be
attributed, in part, to the freeze-drying step of the process, resulting in subsequent breakage of
astaxanthin-protein linkages as mentioned by H.-M. Chen (1981). Additionally, the UAE
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processing treatment of CB with ultrasound energy using the processing chamber facilitated AX
release from the shell more than with using the conventional extraction method, similarly to the
process of releasing biologically active compounds from bacterial cells used by (Mohideen et al.,
2015).
During the accelerated oxidation of the oil samples at 65 °C, the POV increased linearly
with heating the samples containing AX (see Figure 2.17). The linear regression coefficients
were above 0.92 for the heated samples, and 0.7159 for FO at room temperature. Furthermore, a
slower increase in oxidation is seen by the slopes of POV time curves for samples containing AX
being below that of HFO (slope = 0.4086). The slopes of the POV time curves were 0.1508 for
FOCAXUAE at 65 °C, 0.1851 for FOCAX at 65 °C, and 0.2401 for FOCAX at 65 °C are all
lower than HFO. Of the heated oils containing AX, FOCAXUAE and FOCAX had the lowest
POV after 1, 2, 3, and 4 hours of storage at 65 ºC. The function of astaxanthin as an antioxidant
is protecting the FA within the flaxseed oil by scavenging the ROS and by stalling the
propagation phase.
The POV and FFA analysis of an oil are an indication of how good or bad the oil is at the
present time. FFAs are also responsible for the acidity of oil. Increases in FFA content are
mainly correlated to hydrolytic reactions in the oil that release glycerol and fatty acids. These
reactions can be attributed to the moisture present in the oil. Compared to a study extracting
astaxanthin from krill by Ali-Nehari et al. (2012), the oil used in the extraction methods here at
relatively lower (25 ºC for UAE) and higher (60 ºC for conventional extraction) temperatures in
this study had lower FFA content, thus having a lower aw and moisture content, as opposed to oil
exposed to slightly higher temperatures (35 ºC, 40 ºC, and 45 ºC).
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Figure 2.17. Peroxide values FO, HFO, FOCAX, FOSAX, and FOCAXUAE. FOCAX =
Flaxseed oil containing crawfish astaxanthin heated at 65º C for 0-4 h; FOSAX = Flaxseed oil
containing shrimp astaxanthin heated at 65º C for 0-4 h; FOCAXUAE = Flaxseed oil containing
crawfish astaxanthin from ultrasound assisted extraction heated at 65º C for 0-4 h; HFO =
Flaxseed oil heated at 65º C for 0-4 h; FO = Flaxseed oil not heated for 0-4 h.
Table 2.5 Slope, y intercept, and correlation coefficients for linear regression of POV of Oils not
heated and heated at 65 ºC vs. time.
Oil sample
FO
HFO
FOSAX
FOCAX
FOCAXUAE

Slope

y Intercept

0.165
0.4086
0.2401
0.1851
0.1508

0.2267
1.7832
1.832
1.7177
1.6335

Linear regression
coefficient
0.7159
0.9615
0.9986
0.9952
0.9257

FOSAX = Flaxseed oil containing astaxanthin heated at 65º C; FOCAX = Flaxseed oil
containing astaxanthin heated at 65º C; FOCAXUAE = Flaxseed oil containing crawfish
astaxanthin from ultrasound assisted extraction heated at 65º C; HFO = Flaxseed oil heated at 65º
C; FO = Flaxseed oil at room temperature.
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Figure 2.18. Thiobarbituric acid reactive substances of HFO, FOCAX, FOSAX, and
FOCAXUAE samples at 65 ºC. FOCAX = Flaxseed oil containing crawfish astaxanthin heated at
65º C for 0-4 h; FOSAX = Flaxseed oil containing shrimp astaxanthin heated at 65º C for 0-4 h;
FOCAXUAE = 25 g Flaxseed oil containing crawfish astaxanthin from ultrasound assisted
extraction heated at 65º C for 0-4 h; HFO = Flaxseed oil heated at 65º C for 0-4 h.
2.3.5

DPPH (2,2 diphenyl-1-picryl-hydrazyl-hydrate) radical scavenging activity
Antioxidant activity of AX extracts were determined by DPPH radical-scavenging assay

(Roy et al., 2010). DPPH, a stable free radical at room temperature, has been used to evaluate the
effectiveness of various antioxidant substances at free radical scavenging. The ability of
astaxanthin extracts to inhibit the DPPH reaction was expressed in DPPH• inhibition (%) as
shown in Figure 2.18. The decolorization of DPPH solution from purple to a yellow-colored
compound (Reaction 2.1.), which is dependent upon the extent of hydrogen-donating ability
during the reaction, is related to the decrease in the absorbance at 517 nm (Nagarajan, Rani,
Narayanasamy, & Masthan, 2019).
DPPH• + AH®DPPH-H + A•

(Reaction 2.1.)
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The higher the DPPH scavenging (% inhibition), the higher the antioxidant activity of the
sample. The FOCAXUAE sample had the greatest DPPH• scavenging ability, of all the samples
and concentrations used and exhibited a higher DPPH scavenging activity than that of the control
throughout the assay. At the end of the period, all the samples, except for the control (FO)
showed scavenging activity greater than 50%. The results are in agreement with data reported by
Taksima, Limpawattana, and Klaypradit (2015), supporting that AX functions as an antioxidant
in donating H to terminate the chain reaction in lipid oxidation. Other researches have also
reported that astaxanthin has a primary antioxidant function by donating electrons to unpaired
electrons to neutralize free radicals or abstracting an unpaired electron which also can neutralize
a radical (Kidd, 2011). The propagation step of lipid peroxidation is inhibited by the interaction
of AX with free radicals and with oxygen.
The scavenging effect of AX extracts and standard FO on the DPPH• decreased in the
order of FOCAXUAE (1.9 mg.g-1 oil), FOCAX (0.92 mg.g-1 oil), FOSAX (0.54 mg.g-1 oil), FO
(0.0 mg.g-1 oil) equivalent to ascorbic acid (20 mg.100 ml-1 ethanol), 85.85, 82.97, 82.82, and
70.85%, respectively.
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Figure 2.19 Antioxidant activity of different astaxanthin extracts in flaxseed oil determined by
DPPH scavenging activity. FOCAX = flaxseed oil containing astaxanthin (0.92 mg/g)
conventionally extracted from crawfish processing byproducts (n = 3). FOSAX = flaxseed oil
containing astaxanthin (0.54 mg/g) conventionally extracted from shrimp processing byproducts
(n = 3). FOCAXUAE = 25 g flaxseed oil containing astaxanthin (1.9 mg/g) from ultrasound
assisted extraction of crawfish processing byproducts (n = 3). FO = flaxseed oil. Error bars
indicate standard deviations.
.
For the reduction of DPPH, the standard curve was linear between 0–20 mg of ascorbic
acid/100 mL. The absorbance response (y) of vitamin C (y = − 0.039x + 0.0683, r2 = 0.9785)
concentrations was linear, having a strong coefficient of determination. The activity of three
different extracts and the control was determined, with all tests performed in triplicate. The
greatest DPPH• inhibition % after 30 minutes was with FOCAXUAE, 80.18±1.02, with FOCAX
and FOSAX behind, 58.44±0.22 and 50.71±0.33, respectively. The differences in antioxidative
activity between extracts were mostly due to the slightly differing concentrations of AX present.
Additionally, the potential isomerization of the astaxanthin molecule contributes to the increased
DPPH• scavenging activity. S. Yang et al. (2015) reported that in 9-cis-astaxanthin has a greater
antioxidant activity than 13-cis-astaxanthin, and the predominant naturally found, all-transastaxanthin. According to S. Yang et al. (2015), thermal processing has been found to induce the
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formation of 9-cis-astaxanthin. Recall, that the crawfish processing byproducts had been
thermally processed (parboiled) before the analyses.
2.4

Conclusion
Preliminary investigations of total extractable AX using solvents revealed that crawfish

processing byproducts consisted of more astaxanthin than shrimp processing byproducts.
Therefore, future investigations will focus on crawfish processing byproducts. Flaxseed oil
containing astaxanthin (FOAX) derived from crawfish processing byproducts (CB) or shrimp
processing byproducts (SB) were produced by extraction with two different techniques. The
conventional method used to produce FOAX required more time and used a larger quantity of a
valuable solvent, flaxseed oil (FO). A novel method was designed, developed and tested that
produced greater yields of astaxanthin than conventional methods. The novel method employs
the use of ultrasonication and ethanol combined with FO in a continuous system. The different
extraction methods and types of processing byproducts showed significant differences in the
amount of AX extracted. Even pre-treatment improved the recovery of extractable astaxanthin.
Previous studies suggest similar end results (H.-M. Chen & S. P. Meyers, 1982). The FOAX
created in all extraction methods had a specific gravity similar to the control FO. Color data
revealed a significant relationship between a* and AC. Color data did not reveal any other
significant information as it pertained to any quality parameters evaluated. FOAX from CB by
ultrasound assisted extraction (UAE) had a significantly lower moisture content than the other
FOAX extracts. The FOCAXUAE exhibited a greater oxidative stability than other FOAX
extracts, FOCAX or FOSAX, by conventional extraction. Additionally, astaxanthin recovery
using the combined ethanol and flaxseed oil UAE method was more efficient than conventional
extraction method, recovering more than twice the amount of astaxanthin. Compared to other
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extraction methods considered, the utilization of ultrasound sonication combined with ethanol
and flaxseed oil in a closed system proved to be capable of improving the extraction efficiency of
astaxanthin (w/w). and minimizing the lipid oxidation significantly compared to CFO.
Additionally, the antioxidant capacity was greatest with the utilization of freeze-dried parboiled
CB for UAE.
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CHAPTER 3
DEVELOPING ENTRAPPED FLAXSEED OIL
CONTAINING CRAWFISH ASTAXANTHIN IN A PECTIN-GELATIN
MATRIX GUMMY
3.1

Introduction
The increasing public perception of the correlation between diet and human health, has

caused food manufacturers to developed various foods with health-promoting/protective
compounds. Many of those compounds are dietary carotenoids (antioxidants), nutrients that
impart protective effects on human health. Astaxanthin (AX) is a natural pigment that imparts
red color to microalgae, salmon, trout, shrimp, crawfish, and flamingos. Moreover, AX has been
shown to reduce the risk of developing cardiovascular disease, age-related macular degeneration,
and breast cancer (Fassett & Coombes, 2012; Grimmig, Kim, Nash, Bickford, & Shytle, 2017;
Inoue et al., 2017; Satoh, 2016).
The efficiency of carotenoids absorption (bioaccessibility) may limit their biological
actions. Carotenoids are highly lipophilic molecules and must be incorporated within delivery
systems to overcome physiological or physicochemical challenges that limit their efficacy, such
as an unsuitable matrix, which directly impacts oral bioavailability, and chemical, or biochemical
instability; and poor water solubility (McClements & Li, 2010). Emulsion-based delivery
systems are one of the most suitable candidates for entrapping and delivering lipophilic
biologically active compounds and they are relatively simple and economical to produce (Z.
Zhang, Zhang, Chen, Tong, & McClements, 2015). Examples of such delivery systems include
nanofibers, filled hydrogel particles, and colloidal suspensions such as emulsions,
microemulsions, nanoemulsions, and multiple emulsions.
The consumption of dietary carotenoids is reported to have an inverse relationship with
the risk of major clinical diseases, such as cancer. Dietary carotenoids have health benefits that
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are associated with their bioavailability and metabolic fate. However, due to the lipophilic nature
of astaxanthin and poor solubility in water, it has a low bioavailability. Therefore, a vehicle for
effective delivery of astaxanthin is needed. Delivery of bioactive compounds to a right place at a
right time or controlled release of a compound is one of the important roles of encapsulation.
Encapsulation for controlled release could improve the bioaccessibility of biologically active
compounds, increase the application range of food ingredients and ensure effective dosing (Desai
& Park, 2005; Lu, 2017; Trojer, Nordstierna, Nordin, Nydén, & Holmberg, 2013). A specific
barrier formed by encapsulation manipulates release of active compounds to provide functional
benefits and unique sensory properties (Lakkis, 2007).
Hydrogels formed by cross-linkages between hydrophilic polymeric chains may be
natural or synthetic (Matalanis, Decker, & McClements, 2012; Neves et al., 2015). The structural
integrity of a hydrogel depends on the crosslinks formed between polymeric chains, via different
types of physical interactions of chemical bonds (Neves et al., 2015). Typically, a filled hydrogel
contains oil droplets trapped within the biopolymer network (Z. Zhang et al., 2015). Gelatin may
have a very glossy surface due to the amount of regular reflection from the surface being high
and the amount of diffuse low. Conversely, gummies containing HPMC have visually matte
surfaces with greater amount of diffuse reflection, suggesting a more irregular surface.
Astaxanthin has gained much medical attention due to its health protective benefits.
Astaxanthin, is a naturally occurring antioxidant that can neutralize unstable free radicals that are
linked with the development of a number of diseases such as cancer, cardiovascular disease and
age conditions such as Alzheimer’s and macular degeneration. The biological activity of
astaxanthin is highly dependent on intestinal absorption, and is why the food matrix or other
delivery system is important. Several delivery systems have been developed as carriers for
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astaxanthin to protect its biological activity from environmental factors and enhance its stability.
Such delivery systems include nanodispersions, microencapsulations, and lipid carriers(Hama et
al., 2012; I Higuera-Ciapara, Felix-Valenzuela, Goycoolea, & Argüelles-Monal, 2004; Xiaojuan
Liu et al., 2018; Shen, Zhao, Lu, & Guo, 2018; Tamjidi, Shahedi, Varshosaz, & Nasirpour, 2014,
2018). Previous work has also investigated the encapsulation of a lipid extract containing
astaxanthin by complex coacervation using gelatin and cashew gum (Gomez-Estaca, Comunian,
Montero, Ferro-Furtado, & Fávaro-Trindade, 2016).
In the present work, the efficiency of lm-pectin-gelatin and hm-pectin-gelatin
coacervation systems with and with hydroxypropyl methylcellulose (HPMC) to encapsulate core
material (FOCAXUAE) were compared. Qi et al. (2013) reported a key interaction between bile
salts in the gut environment and HPMC that resulted in dissolution and subsequent absorption of
water-soluble drugs. The inclusion of HPMC into the delivery system contributed to
micellarization and intestinal absorption of astaxanthin. The loading efficiency and release
characteristics of the two coacervation systems (with and without HPMC) were considered.
3.2

Materials and Methods
Gelatin solutions were prepared by hydrating type A gelatin (Knox Original Gelatine,

Unflavored, Kraft Foods, Northfield, IL), purchased from a local grocery store, in distilled water.
Pectin solutions were prepared separately with high-methoxyl pectin (Pre-Hydrated® HM Rapid
Powder, HMP, Lot # 43621, DE>50%, 181 kDa mw) and low-methoxyl pectin (TIC Pretested®
Pectin LM 32 Powder, LMP, Lot # 571091, 32% DE, 130 kDa mw), both kindly provided by
TIC Gums (Belcamp, MD), to distilled water with agitation overnight to ensure complete
hydration. Sunflower lecithin powder (lecithin, see Table 3.1 for lipid content) was purchased
from Now Foods (Bloomingdale, IL). Hydroxypropyl methylcellulose (HPMC, MW ∼10 kDa,
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methoxyl content ~28 wt. %, hydroxypropoxy content ~9.5 wt. %, equivalent to Methocel E,
viscosity grade 60 cP, Alfa Aesar, Germany), and was purchased from Fisher Scientific. Ethanol
(190 proof), chloroform, and methanol were all analytical grade solvents.
Sunflower lecithin (5% wt. of FOCAXUAE wt.) was used as emulsifier to prepare the oil
phase containing sodium deoxycholate (1% wt. of FOCAXUAE). This oil phase was manually
distributed into the aqueous phase to an oil fraction of 32 g/ 26 g of pectin solution (10% wt.).
The coarse O/W emulsions obtained were sonicated using an ultrasound processor (Cole Palmer)
in a dry ice, ethanol slurry under a nitrogen flux to prevent thermally induced lipid oxidation.
High-methoxyl apple pectin (HMP) and low-methoxyl pectin (LMP) were kindly
provided by TIC Gums (Belcamp, MD). Glucose syrup (Karo Light corn syrup, ACH Food
Companies, Inc., Oakbrook Terrace, IL, USA) was purchased from Walmart.
Table 3.1. Phospholipid content in sunflower-lecithin.
Naturally occurring phospholipids (per serving) (10 g):
Phosphatidyl Choline

2.5 g

Phosphatidyl Inositol

1.8 g

Phosphatidyl Ethanolamine

1.1 g

3.2.1

Preparation of FOCAXUAE for gummy fabrication
A stock FOCAXUAE was prepared by concentrating (5) subsequent FOCAXUAE

extractions with the same FO and E ratio as previously described in section 2.2.3.2. of Chapter 2,
with slight modification. To effectively concentrate astaxanthin, crawfish processing byproducts
(CB) were replaced with a new batch of CB after each 10-minute ultrasound assisted extraction
cycle. Following the extraction period, the CB were washed with ethanol until clear. Then the
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filtrate was pooled and complete evaporation of the ethanol was accomplished by using a rotary
evaporator (Büchi Rotavapor R-114, Büchi Labortechnik AG, Flawil, Switzerland). This
produced a concentrated FOCAXUAE (35 ml).
3.2.2

Preparation of Emulsions
Oil in water emulsions with desired concentrations of low- or high-methoxyl pectin

containing concentrated FOCAXUAE were prepared by a method of Couëdelo et al. (2010) at
room temperature with slight modification. The aqueous phase, emulsifier solution was prepared
by first dissolving HMP or LMP in distilled water overnight to allow complete hydration,
followed by the subsequent addition of lecithin (20% wt. of oil). The amount of FOCAXUAE in
the O/W emulsion was adjusted so that each gummy contained approximately 10% FOCAXUAE
of the total weight of the gummy after setting. Emulsions prepared with HPMC, were prepared
without lecithin.
3.2.2.1 Emulsion Stability
The stability of the emulsions was assessed according to a method described by
Mohideen (2011) with modifications. Emulsion samples (3 g each) were placed in 13 x 100 mm
disposable borosilicate glass culture tubes (Kimble, Vineland, NJ) in a tube rack on a benchtop at
room temperature (25±0.5 °C) for 2 days. Next the samples were centrifuged at 1163 x g for 30
minutes (BD-Clay Adams Compact II centrifuge), and the amount of emulsion cream separated
was measured. To determine the emulsion stability, or inability of phases to separate, the percent
of oil to separate from the emulsion must be calculated. The oil recovery percentage was
calculated using equation 3.1. The emulsion stability (ES) was determined using equation 3.2.
"#$ &'()*'&+ ("-) % =

123456 78 739 :2;7<2:2=
>?@9A37B 123456 (3B363C9)

× 100
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(Eq. 3.1)

where oil separated is the weight of the oil separated from the cream layer after centrifugation
treatment.
GHI$J#)K LMNO#$#M+ (GL) = 100 % − "-%
3.2.3

(Eq. 3.2)

Formulation and production of pectin-gelatin delivery system
Pectin-gelatin delivery system (PGDS) were prepared using the method of DeMars and

Ziegler (2001) with modifications. Table 3.2 shows the PGDS recipes. Figure 3.2 is a flow
diagram for the preparation of the gummies. Each batch was made using the same amounts for
sugar slurries (brought to 240 g by addition of distilled water). O/W emulsions were prepared
such that when added to gelling slurries (gelatin, ~15-30 g) and the desired amount of gelatin and
pectin were achieved. Gelling slurries were formulated such that the final PGDS contained the
desired concentration of pectin and gelatin to facilitate associative interactions without
precipitation of either. Additionally, for a confectionery gummy production, it is essential to
include glucose syrup in proportional amounts to sugar (1:1) to prevent crystallization of the
sugar. In the present work, the word “gummy” and “PGDS” are used interchangeably.
After both solutions (gelling slurry and sugar slurry) were mixed under constant stirring
for 10 minutes, the homogenous viscous solutions obtained were poured into 160 square cavity
silicone molds. Each resulting gummy cube had a volume of 1 cm3 (quantity of solutions
deposited in the mold were estimated to be the same for all gummies when pouring). Once the
trays filled, they were placed in the refrigerator for 48 hours to achieve gel consistency. Each
gummy candy weighed 1±0.03 g. After gelling they were removed from the molds and lightly
dusted with powdered sugar to prevent them from sticking. They were then placed in square 5.5
in. x 5.5 in. weigh dishes to dry at room temperature (25±0.5 ºC) for another 48 h. For release
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PGDS cubes were placed in separate conical tubes (50 ml) and refrigerated. PGDS with FO in
the emulsion preparation step was prepared as a blank.
Table 3.2. Design and development of pectin-gelatin gummy pieces.
PGDS1
PGDS2
PGDS3 PGDS4 PGDS5 PGDS6 PGDS7
(pH 3.55) (pH 2.85) (pH 2.8) (pH 2.8) (pH 2.9) (pH 2.9) (pH 2.9)
Sucrose**
101
111
101
111
111
102
102
Corn syrup**
91
103
91
103
103
90
90
H2O**
100
100
100
120
120
50
50
LMP*
2
4
3
HMP*
4
2
4
3
HPMC*
5% w/w 5% w/w
dH2O*
60
60
Gelatin***
15
30
30
30
30
15
15
H2O***
30
30
30
30
30
20
20
FOCAXUAE*
30
20
20
30
32
32
32
Tween 20
0.27
0.4
0.35
0.4
0.27
0.27
Ascorbic acid
2
2.5
2.7
11.46
3
6
7
Note: PGDS1- PGDS7 are prepared with pectin (LMP or HMP), with or without HPMC,
FOCAXUAE, and distilled (d) H2O*. Sucrose (table sugar), corn syrup (Karo®, ACH Food
Companies, Inc., Oakbrook Terrace, Il.)), and dH2O**. Type-A gelatin hydrated with dH2O***
becomes the gelling solution*** Tween 20 was added during the mixing of the three final
solutions followed by lowering the pH with 50% food grade citric acid solution. HPMC is 5% of
final emulsion (g). The ingredient ratios of PGDS1 were not capable of forming the desired
delivery system, thus no further work was done on PGDS1. 2•
Ingredients (g)

2

* denotes the emulsion containing pectin, dH2O, and FOCAXUAE. ** denotes the sugar slurry, *** denotes the
gelling slurry.
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Figure 3.1. Flow diagram for preparation of FOCAXUAE pectin gelatin delivery system. To
promote coacervation, the pH was changed to ~3 ± .5 with citric acid (50% v/v food grade citric
acid and distilled water) at 25 ± 0.5 °C under a stirring rate of 600 rpm for 30 min to achieve
uniform mixing, complete complex coacervation, and minimize aeration. Source: Muhoza, Xia,
and Zhang (2019).
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3.2.4

Water Activity and soluble solids content of pectin gelatin cubes
After PGDS fabrication, their water activity (aw) were evaluated. The aw of samples was

determined using a Pawkit aw meter (AquaLab Pawkit, Decagon Devices Inc., Pullman, WA) at
25 ± 0.5 °C. To determine total soluble solids (TSS) of the PGDS, distilled water (DW) was
combined with macerated PGDS (1:1 g/g). TSS was then determined from the mixture by
refractometry, using a digital refractometer (AR200, Reichert Analytical Instruments, Depew,
NY, USA) with values expressed in Brix (°Brix). All analyses were carried out in triplicate.
3.2.5

Determination of FOCAXUAE content in PGDS
Using a modified method of Blighs and Dyer (1959) for extracting total lipids, the

astaxanthin content in the PGDS was determined. To quantify the mass (g) of total lipid initially
loaded in a PGDS, a 50 mL tube containing macerated PGDS (5 g ± 0.1) and 2.5 mL DW was
added. Then a ternary solvent system was created as follows: for each gram of sample, 3.75 mL
of 1:2 CHCL3: MeOH was added and vortexed (1000 rpm) until complete dissolution had
occurred or for 90 seconds. Then an additional two mL of DW was mixed with the sample and
vortexed a second time (30 seconds). The alcoholic layer containing non-lipids (top layer) was
carefully removed by aspiration using a syringe and the CHCL3 fraction (bottom layer)
containing the lipids was added to a tared vial. The solvent was evaporated from the tared vial
using an analytical evaporator until constant weight was achieved. The cooled vial was weighed,
and the weight of the lipid residue recorded. Triplicate determinations were performed for each
sample. The average values were recorded as, Total FOCAXUAE content (TFC) in PGDS.
3.2.6

Determination of lipid released and astaxanthin content in PGDS

The amount of lipid released was determined in the same manner as TFC, except that the
released material from the gummies was used instead of macerated gummies. The amount of
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astaxanthin in the gummy was proportional to amount of oil quantified per gummy. Three PGDS
samples were weighed (data recorded as initial PGDS weight) and placed inside 50 mL conical
tubes for dissolution studies.re placed on a tared balance and the weights recorded. For
quantification of lipid released, 11.25 mL of 1:2 CHCL3: MeOH were added to each 50 mL
conical tube containing PGDS samples and 10mL of dissolution media and vortexed (1000 rpm)
for 60 seconds. The alcoholic layer containing non-lipids (top layer) was carefully removed by
aspiration using a syringe and the CHCL3 fraction (bottom layer) containing the lipids was added
to a tared vial. The solvent was evaporated from the tared vial using an analytical evaporator
until constant weight was achieved. The cooled vial was weighed, and the weight of the lipid
residue recorded. Triplicate determinations were performed at each designated time. The
averaged values were recorded as lipid released.
Astaxanthin content of total lipid extracted from the gummy was measured using to the
method of Saito and Regier (1971) with a slight modification. Following “Determination of
FOCAXUAE content in PGDS” (see section 3.2.5.) and the determination of lipid released in
PGDS in this section, 30 mg of recovered oil was mixed with 10 ml of petroleum ether (PE) and
allowed to stand for 30 min. The absorbance of oil, appropriately diluted, was measured at 468
nm using a GENESYS 20 UV-Vis spectrophotometer (Thermo Fisher Scientific, Inc., Rochester,
NY, USA). The concentration (C) of astaxanthin in the PGDS was calculated using the equation
given by Saito and Regier (1971) with a slight modification as follows:
QRS (TU⁄U lipid) =

[\]^ × <79@?2 78 _> × =39@637B 8C;67:
`.b × 123456 78 AC?c92 @A2= 3B 4:C?

(Eq. 3.3) where 0.2 is the A468 of 1 μg/ml standard astaxanthin and 1 is the dilution factor of the
sample.
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3.2.7

Swelling and Release media
In order to examine the potential of the pectin-gelatin delivery system (PGDS) gummy as

a delivery system for bioactive compounds, release characteristics of PGDS with entrapped
FOCAXUAE were investigated in release media. The gastrointestinal (GI) tract environment was
modeled with two simulated digestive fluids as described by Chotiko and Sathivel (2017) and
Taylor et al. (2019) with some modifications. In accordance with the United States
Pharmacopeia, simulated gastric fluid (SGF at pH 1.2, without pepsin) consisted of 2 g of
sodium chloride (Fisher Scientific Inc., Pittsburgh, PA), 7 mL of hydrochloric acid (Fisher
Scientific Inc., Pittsburgh, PA), and distilled water used to adjust the total volume to 1 L. For
simulated intestinal fluid (SIF at pH 6.8, without enzyme), 6.805 g of monobasic potassium
phosphate (Sigma Aldrich, St. Louis, MO) and 0.896 g of sodium hydroxide (Fisher Scientific
Inc., Pittsburgh, PA) were dissolved in distilled water and the total volume was adjusted to 1 L.
3.2.7.1 Swelling Studies
Swelling of hydrogels affects the controlled release of the compounds entrapped in the
hydrogel matrix (Xiudong Liu et al., 2004). To evaluate the water sorption resistance of the
PGDS with entrapped astaxanthin, three samples were weighed (Wd), 1±0.03 g each and then
immersed in 30 mL of dissolution media (distilled water (DW), simulated gastric fluid (SGF pH
1.2) or simulated intestinal fluid (SIF pH 6.8) at 37 °C, with shaking (50 rpm). Swollen gels were
removed from dissolution media at predetermined time intervals, blotted dry, and weighed (Wf)
to track sorption kinetics. The swelling index (SI) was determined as described by (Raafat, Eid,
& El-Arnaouty, 2012) using the equation below. Each tube was initially prepared with equal
volumes of dissolution fluids.
Ld (%) =

ef geh
ef

× 100

(Eq. 3.4)
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Where Wf and Wi are the weights of swollen and dry gummies, respectively
3.2.7.2 In vitro Release Study
Release of astaxanthin from PGDS was investigated in SGF and SIF for 120 and 180
min, respectively as described by Chotiko and Sathivel (2017) and Taylor et al. (2019) with
some modifications. Three grams of PGDS were placed in 50 ml conical tubes containing 10 ml
of SGF or SIF. The tubes were incubated with continuous agitation, at 50 rpm about their
horizontal axis in a circular motion using an orbital shaker incubator equipped with a
temperature control system (37 °C). Three individual tubes were sampled at predetermined time
intervals to determine FOCAXUAE released during incubation. Astaxanthin content in the
gummies was determined by the methods mentioned in sections 3.2.5 and 3.2.6 above.
The amount of lipid released was determined by the method mentioned above in section
3.2.6. With the amount of lipid released and the concentration of astaxanthin (mg) per g of oil,
the bioaccessibility of AX can be determined.
(%) i#)N(('J#O#$#M+ =

C?7@B6 jklmnom> :2;7<2:2= 8:7? _pqr C6 2C;5 63?2 (?4)
C?7@B6 78 jklmnom> 3B363C99s 97C=2= 3B _pqr (?4)

× 100

(.3.5)

Bioaccessibility can be defined as the theoretical amount of astaxanthin available for
absorption. The amount of FOCAXUAE initially loaded per PGDS is ~200 mg per a ~2g gummy
and ~100 mg per 1 g gummy, based on the method in section 3.2.5. Triplicate determinations
were performed for each sample.
3.2.8. Morphology using scanning electron microscopy (FIB-SEM)
Freeze dried gummies (PGDS2, PGDS3, PGDS4, PGDS5, PGDS6, PGDS7) were
mounted on aluminum scanning electron microscopy (SEM) specimen stubs and coated in an
Edwards S150 sputter coater with platinum. Coated gummies were observed using a dual-beam
scanning electron microscope (FEI Quanta 3D FEG FIB-SEM) instrument (Louisiana State
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University, Louisiana) interfaced with EDAX EDS/EBSD system at an acceleration voltage of
5kV and 3 pA under high vacuum. SEM micrographs were used to obtain information about the
surface morphology and encapsulated bioactive compound.
3.2.8

Statistical Analysis
Mean values and standard deviations of triplicate reproducible analyses are reported. The

statistical significance of observed differences among treatment means was evaluated by analysis
of variance (ANOVA) was carried out to determine the difference among treatments means with
SAS software Version 9.4 (SAS Institute Inc., Cary, NC) using a post hoc Tukey's studentized
range test (SAS, 2013).
3.3

Results and Discussion

3.3.1

Water activities, moisture, soluble solids, and astaxanthin content of the delivery
system
Protein and polysaccharide interactions play an important role in the structure and

stability of foods and food products. A key factor in fabricating novel food products is the
control and manipulation of macromolecular interactions between hydrocolloid constituents. The
functional properties of proteins are affected by their interactions with polysaccharides, and vice
versa. Analyses were performed on delivery system to determine the moisture and water activity
of the PGDS samples. Results are shown in Table 3.3. PGDS7 and PGDS6 had the lowest water
activity, which may be due to the hydrophilicity of HPMC, a synthetic polymer, binding more
water.
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Table 3.3. Compositional parameters of pectin gelatin delivery systems (PGDS)
Water activity
Moisture (%)
Soluble solids (ºBrix)
AC (mg)
D
B
C
PGDS2
0.27 ± 0.02 B
0.81 ± 0.011
25.20 ± 0.10
75.27 ± 0.25
B
B
B
B
PGDS3
0.77 ± 0.005
25.03 ± 0.15
73.43 ± 0.02
0.27 ± 0.02
C
B
B
B
PGDS4
0.79 ± 0.006
26.93 ± 0.23
73.24 ± 0.03
0.38 ± 0.04
C
B
A
A
PGDS5
0.79 ± 0.006
27.00 ± 0.2
71.49 ± 0.03
0.43 ± 0.05
B
A
A
A
PGDS6
0.76 ± 0.015
20.76 ± 0.06
71.69 ± 0.01
0.54 ± 0.02
A
A
A
A
PGDS7
0.73 ± 0.003
20.95 ± 0.07
70.73 ± 0.02
0.54 ± 0.01
Note: A-D Means ± SD not containing a letter in common are significantly different (p=0.05).
Each PGDS weighs 1±0.03g. PGDS2 - 2% LMP:8% G, pH 2.85 (5%); PGDS3 - 2%
HMP:8% G pH 2.8 (5%); PGDS4 - 4% LMP:30% G pH 2.8 (8%); PGDS5 - 4% HMP:30%
G pH 2.9 (8%); PGDS6 - 3% LMP:15% G:5% HPMC pH 2.9 (10%); PGDS7 - 3%
HMP:15% G:5% HPMC pH 2.9 (10%); AC = astaxanthin content
Developed gels potentially affect carotenoid bioaccessibility. High-DM pectin increases
the lipolysis, bile salt binding, and micellarization (conversion into micelles) of polar
carotenoids, resulting in increased uptake (Cervantes-Paz et al., 2017). Conversely, low-DM
pectin can reduce the levels of calcium involved in the lipolysis and generation of lipid digestion
products for micelle formation, thus decreasing carotenoid uptake (Devraj et al., 2013).
The admix of ingredients and setting times play an essential role in the formulation and gel
strength of products. The heterogeneous structures produced by the gummy formulations can be seen
in Figure 3.3., Figure 3.4 (glossy concave top surface), Figure 3.5 (glossy concave top surface), Figure
3.6, and Figure 3.7 (incompatibility of gelatin and pectin, concave structures, and surface haze,
respectively), with the exception of PGDS7 and PGDS6 (Figure 3.8. and 3.9. This is explained by the
lack of favorable polymer interactions in forming gel networks with different concentrations of LMP
and lack of cations or the rapid gel formation of different concentrations of HMP at a pH lower than 3
and coalescence of FOCAXUAE droplets. It was reported that an increase in ionic strength of the
media over 0.1 mM decreased the coacervation yield of gelatin (Burgess & Carless, 1985). The SIF
had an ionic strength greater than 0.1 mM as a result of the 0.896 g of NaOH/liter (0.22 mM),
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therefore further complex coacervation between gelatin and pectin was unlikely to occur. This
supports the need for HPMC in developing a gel that is capable of withstanding the GI environment.

Figure 3.2. Addition of FOCAXUAE to
emulsion with pectin and gelatin.

Figure 3.3. PGDS1 - 4% HMP:15% G pH
3.55 (12%).

Figure 3.4. PGDS2 - 2% LMP:8% G,
pH 2.85 (5%).

Figure 3.5. PGDS3 - 2% HMP:8% G pH
2.8 (5%).
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Figure 3.6. PGDS4 - 4% LMP:30% G
pH 2.8 (8%).

Figure 3.7. PGDS5 - 4%
HMP:30% G pH 2.9 (8%).

Figure 3.8. PGDS6 - 3% LMP:15% G:5%
HPMC pH 2.9 (10%).

Figure 3.9. PGDS7 - 4% LMP:15%
G:5% HPMC pH 3.55 (10%).

The segregative interactions among pectin and gelatin biopolymers (without a nonionic
surfactant (HPMC)) are seen in Figure 3.3. The emulsion phase containing FOCAXUAE can be
seen atop the translucent gelatin phase, Figure 3.3. With PGDS1, it is clear that the upper phase
is rich in FOCAXUAE: pectin (reddish orange in color) while the lower is rich in gelatin
(translucent). The segregation is due to the incompatibility between positively charged gelatin
(pI∼7) and neutral FOCAXUAE: pectin. Phase separation due to the segregative interactions
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occurs above a certain concentration of polymers at which they become thermodynamically
favorable (Doublier, Garnier, Renard, & Sanchez, 2000).
3.3.2

Swelling and Release Study
According to previous research by Sriamornsak, Nunthanid, Cheewatanakornkool, and

Manchun (2010), the release of a compound from a hydrogel matrix is divided into two phases,
rapid release period, and a declining rate period. In some cases, the first phase would be
governed by two mechanisms that dictate drug compounds release from a matrix, swelling and
diffusion. The second phase, is more or less a period of steady release or erosion, rather than a
declining rate, although that rate is lower than the rate of release due to swelling and diffusion.
During such period, the gel swelling has reached equilibrium (Brannon-Peppas & Peppas, 1991).
However, such phenomena are seen with water-soluble compounds integrated in a matrix, while
for low water-soluble compounds like carotenoids, self-erosion of the matrix is the primary
release mechanism.
Release of FOCAXUAE from the delivery systems was investigated in SIF and SGF.
When incorporating bioactive compounds into a product for human consumption, one factor that
goes into the development and design is the delivery system, which encompasses the release of
the bioactive components into a targeted region to facilitate their absorption.
3.3.2.1 Swelling Study
The swelling index indicates the percentage swelling of the delivery system caused by the
uptake of the dissolution media and subsequent growth. With there being no polymer erosion, the
water uptake and swelling resulted in an increase in weight. Greater water uptake was seen in
PGDS7 (high-methoxyl) than with PGDS6 (low-methoxyl) in SIF, SGF, and DW dissolution
medias, Figure 3.10 and Figure 3.11, respectively. Water uptake between PGDS7 and PGDS6
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did not differ in DW, see Figure 3.12. Swelling initially occurred, within 15 minutes, among all
formulations in both SGF at pH 1.2 and SIF at pH 6.8. Swelling was most profound in SIF for
PGDS7 with a SI of 126.46±5.1% after 180 minutes followed by PGDS6 with a SI of
90.61±6.8% after 60 minutes. This further confirms that the prepared delivery systems, PGDS6
and PGDS7, have the capability to withstand the intestinal tract and its environments. The other
delivery systems failed to maintain their structure and either gelled or eroded completely and had
swelling indices under 30%. The large swelling indices of HPMC gummies (PGDS7 and
PGDS6) can be attributed to the hydrophilicity of HPMC.

Figure 3.10. Swelling index studies of pectin-gelatin based delivery systems loaded with
FOCAXUAE in simulated intestinal fluid (SIF pH 6.8). PGDS7, 3% high-methoxyl pectin 15%
gelatin gummies coated with HPMC (5% wt.) pH 3.55; PGDS6, 3% low-methoxyl pectin 15%
gelatin gummies coated with HPMC (5% wt.) pH 2.9; PGDS5, 4% high-methoxyl pectin 30%
gelatin gummies pH 2.9; PGDS4, 4% low-methoxyl pectin 30% gelatin gummies pH 2.8;
PGDS3, 2% high-methoxyl pectin 8% gelatin gummies pH 2.8; PGDS2, 2% low-methoxyl
pectin 8% gelatin gummies pH 2.85.
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Figure 3.11. Swelling index studies of pectin-gelatin based delivery systems loaded with
FOCAXUAE in simulated gastric fluid (SGF pH 1.2). PGDS7, 3% high-methoxyl pectin 15%
gelatin gummies coated with HPMC (5% wt.) pH 3.55; PGDS6, 3% low-methoxyl pectin 15%
gelatin gummies coated with HPMC (5% wt.) pH 2.9; PGDS5, 4% high-methoxyl pectin 30%
gelatin gummies pH 2.9; PGDS4, 4% low-methoxyl pectin 30% gelatin gummies pH 2.8;
PGDS3, 2% high-methoxyl pectin 8% gelatin gummies pH 2.8; PGDS2, 2% low-methoxyl
pectin 8% gelatin gummies pH 2.85.

Figure 3.12. Swelling index studies of pectin-gelatin based delivery systems loaded with
FOCAXUAE in distilled water (DW). PGDS7, 3% high-methoxyl pectin 15% gelatin gummies
coated with HPMC (5% wt.) pH 3.55; PGDS6, 3% low-methoxyl pectin 15% gelatin gummies
coated with HPMC (5% wt.) pH 2.9; PGDS5, 4% high-methoxyl pectin 30% gelatin gummies
pH 2.9; PGDS4, 4% low-methoxyl pectin 30% gelatin gummies pH 2.8; PGDS3, 2% highmethoxyl pectin 8% gelatin gummies pH 2.8; PGDS2, 2% low-methoxyl pectin 8% gelatin
gummies pH 2.85.
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3.3.2.2 Releasing Study
Despite the formation of a gel due to the presence of gelatin, the absence of divalent
cations in the media used to prepare the PDGS prevent LMP gummies from forming junctions
and a network of polymer chains to entrap FOCAXUAE. Thus, making PGDSs formulated with
LMP incapable of controlling the release of FOCAXUAE, see Figures . LMP is capable of
forming three dimensional rigid and water insoluble hydrogels through ionic interactions
between divalent cations (i.e., Ca2+), and the free carboxyl groups of the pectin (Powell, Morris,
Gidley, & Rees, 1982). PGDS formulations containing HMP were under the potential gelling
conditions required (i.e., necessary concentration of pectin, pH, concentration of sucrose) during
preparation. HMPs added gel forming ability was increased at lower pH (SGF, pH 1.2), as
compared to the pH of SIF (pH 6.8), therefore slowing the release of astaxanthin in SGF. Gel
formation of HMPs only occur when the pH value is sufficiently low to suppress the electrostatic
repulsions between charged carboxyl groups (–CO2H or –COOH) resulting in increased hydrogen
bonding and hydrophobic interactions between the pectin molecules (Löfgren & Hermansson, 2007).
The same would be the case for LMP if divalent cations were present.
None of the PGDS gummies tested in SGF dissolution media were able to prevent release
of FOCAXUAE into the stomach milieu mimicking solution. However, with PGDS7 and
PGDS6, the acid environment of SGF dissolution media was slower to degrade the HPMC
coating. The HPMC provides gastric-resistant properties, which resulted in a delayed liberation
of the incorporated FOCAXUAE (Cole et al., 2002), reported similar finding using HPMC as an
enteric coating. However, if the FOCAXUAE would have been encapsulated by pectin in the
PGDS gummies without HPMC, early release may have been slowed or prevented. According to
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the release study, gels with pectin dissolved slower in SGF than SIF. To mimic the GI tract
transit times, the gels were only subjected to SGF for 120 minutes, and to SIF for 180 minutes.

Figure 3.13. Release characteristics of pectin-gelatin based delivery systems loaded with
FOCAXUAE in simulated gastric fluid (SGF pH 1.2). PGDS7, 3% high-methoxyl pectin 15%
gelatin gummies coated with HPMC (5% wt.) pH 3.55; PGDS6, 3% low-methoxyl pectin 15%
gelatin gummies coated with HPMC (5% wt.) pH 2.9; PGDS5, 4% high-methoxyl pectin 30%
gelatin gummies pH 2.9; PGDS4, 4% low-methoxyl pectin 30% gelatin gummies pH 2.8;
PGDS3, 2% high-methoxyl pectin 8% gelatin gummies pH 2.8; PGDS2, 2% low-methoxyl
pectin 8% gelatin gummies pH 2.85.
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Figure 3.14. Release characteristics of pectin-gelatin based delivery systems loaded with
FOCAXUAE in simulated intestinal fluid (SIF pH 6.8). PGDS7, 3% high-methoxyl pectin 15%
gelatin gummies coated with HPMC (5% wt.) pH 3.55; PGDS6, 3% low-methoxyl pectin 15%
gelatin gummies coated with HPMC (5% wt.) pH 2.9; PGDS5, 4% high-methoxyl pectin 30%
gelatin gummies pH 2.9; PGDS4, 4% low-methoxyl pectin 30% gelatin gummies pH 2.8;
PGDS3, 2% high-methoxyl pectin 8% gelatin gummies pH 2.8; PGDS2, 2% low-methoxyl
pectin 8% gelatin gummies pH 2.85.
3.3.3

Micrographs of pectin-gelatin delivery systems
FIB-SEM images of the PGDSs revealed some physical attributes to explain the burst

seen in the release profiles and further explained the releases characteristics observed. For
instance, the lack of homogeneity and ordered distribution of the FOCAXUAE within the
PGDS2, PGDS3, PGDS4, and PGDS5 explains the trends seen in the release profiles. Perhaps,
the lack of favorable interactions occurring within the colloid system during preparations
resulted in the separating out of the bioactive compounds, coalesced lipid droplets (arrows in
Figure 3.15A-D), however, with PGDS3 and PGDS5, Figure 3.15B and D, there are fewer
formless globules seen. With the formulations of PGDS2-5 samples with consistent release
characteristics among the treatments (n=5) could not be generated. However, with the addition
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HPMC, better release characteristics were seen and apparent by the structures seen in the
micrographs below, Figure 3.11. E and F (arrows show double encapsulated FOCAXUAE.

A

B

C

D

E

F

Figure 3.15. Scanning electron micrograph of cross-section of PGDS sample, after freeze drying
(350 to 3,500x magnification). PGDS2 (A) - 2% LMP:8% G, pH 2.85 (5%); PGDS3 (B) - 2%
HMP:8% G pH 2.8 (5%); PGDS4 (C) - 4% LMP:30% G pH 2.8 (8%); (caption cont'd).
106

PGDS5 (D) - 4% HMP:30% G pH 2.9 (8%); PGDS6 (E) - 3% LMP:15% G:5% HPMC pH 2.9
(10%); PGDS7 (F) - 3% HMP:15% G:5% HPMC pH 2.9 (10%). Shaded arrows in E and D
indicate double encapsulation.
Initially, it was expected that LMP would be more compatible with gelatin and would
form a single-phase system, compared to HMP and gelatin. However, the inability of LMP in
encapsulating FOCAXUAE and the lack of gel formation proved otherwise. Furthermore, the gel
forming capabilities of HMP were not affected by the presence of a second or third polymer.
However, the presence of HPMC did induce the formation of capsules. Studies have reported the
ability of high concentrations of Na+ and K+ ions induce gelation, regardless of alkali hydroxides
NaOH and KOH preventing gelation due to demethoxylation (Wehr, Menzies, & Blamey, 2004).
This explains the inability of LMP to retain a gel in SIF.
3.3.4

Characterization of the PGDS
The FOCAXUAE is encapsulated in a double emulsion of pectin and HPMC within the

gelatin network that appeared heterogeneous in size, PGDS6 and PGDS7, Figure 3.15E and F,
respectively. However, in the formulation with HMP, Figure 3.15F, there was greater uniformity
among the size of the capsules. The PGDS without HPMC showed less uniformity, as there were
FOCAXUAE globules (formless shapes) of FOCAXUAE in cross sections of the freeze-dried
hydrogels (Figure 3.11A-C) or a small number of FOCAXUAE droplets (Figure 3.15D). The
SEM images obtained are representative of high encapsulation efficiency, which was 94 ± 1%
for the three samples.
Moreover, high-methoxyl pectin had a high encapsulation efficiency (89.2%) and
contributed to the controlled release of FOCAXUAE in both SIF and SGF with and without
HPMC. HMP solutions gel because of hydrophobic interactions and hydrogen bonding between
pectin molecules, while LMP solutions rcquire a sufficient concentration of divalent cations to
gel. The initial burst release (within the first 15 minutes) is thought to be caused by poorly
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entrapped FOCAXUAE, weak network formation from highly hydrated and charged carboxylate
groups, or the FOCAXUAE adsorbed onto the outside of the particles. The very glossy surface
of the PGDS cubes is because the amount of regular reflection from the surface is high and the
amount of diffuse reflection is low. In contrast, HPMC capsules have a visually matt surface
with a greater amount of diffuse reflection, suggestive of a more irregular surface. This may
imply possible formation of an enteric barrier around the PGDS gummies
The PGDS (PGDS6 and PGDS7) prepared with HPMC (%5 wt./wt. of final volume)
resulted in a delay of the burst release of FOCAXUAE, which can be attributed to a film coating
developing around the delivery system when exposed to a near neutral solution. Release of AX
from the PGDS matrix was investigated and, in an effort to examine the potential of the pectingelatin gummy confectionary as a lymphatic delivery system release characteristic were
evaluated.
Despite the high concentration of sugar, it appears that HPMC particle swelling and
coalescence may not have been suppressed, as it was in a study by Williams, Ward, Hardy, and
Melia (2009). Based on data obtained from the swelling study, PGDS with HPMC (5% wt.) had
extensive swelling for 180 min in SIF, but not in SGF. It is hypothesized that disintegration
occurred after the three-hour exposure to SIF during the swelling study, as it did for the other
formulations in both SGF and SIF. That hypothesis is validated by the absence of a burst release
phenomena when evaluating the release profiles. The

swelling studies in SGF

showed that PGDS formulated without a concentration of HPMC to produce an enteric coating
disintegrated rapidly. It should be noted that an enteric coating may possibly hinder the intestinal
uptake and absorption of AX in the lymphatic system. Consequently, the gel barrier was not
capable of tolerating the low pH of the SGF, thus making AX available. Aside from the subtle
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swelling occurring, in the SGF, you can see that there is less burst of oil release from PGDS6 and
PGDS7. In all other formulations, there was no gel layer formation on the surface of the PGDS,
therefore the matrix had immediate release characteristics. Weaker gel layers were formed in
PGDS2, PGDS3, PGDS4, and PGDS5, as evidenced by the fact that no data could be collected
from the swelling study. In PGDS formulated without HPMC, the release of FOCAXUAE was
unavoidable. Looking at the formulations combining gelatin with HMP, there was an associative
interaction between the two polymers and neither component had an effect on the other. The gel
strength of PGDS4, PGDS5, PGDS6 and PGDS7 was evidenced by their firmness when
compressed between the index and thumb fingers and their retained shape (by visual inspection).
HMP gels when the molecules are hydrated, and subsequently lose some of the water
(dehydration) due to the presence of co-solutes, i.e., high concentrations of sugar. Dehydration
causes the pectin molecules to form hydrogen bonds between chains, resulting in a decrease in
electrostatic forces (decrease in cross-linking by divalent cations). Those hydrogen bonds create
a network to trap the remaining water and solute molecules. In this case, PGDS2 and PGDS5,
despite the inability of the pectin to encapsulate the FOCAXUAE, the properties of HPMC
within the PGDS6 and PGDS7 formulations create the conditions necessary to form a network to
protect the bioactive compound. The resulting formulation contained a double emulsion.
3.4

Conclusion
A hydrocolloid delivery system, which incorporated the astaxanthin (in flaxseed oil) into

edible gummies, was designed, developed and tested. The delivery system was tested in
simulated gastric fluid (SGF) and simulated intestinal fluid (SIF), and performed well. It
withstood SGF for typical stomach transit times and released the flaxseed oil (solvent)
containing astaxanthin within normal GI tract times when tested in the simulated intestinal
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environment. Rapid release of FOCAXUAE from pectin:gelatin:HPMC delivery systems was
prevented by the presence of the cellulose derivative HPMC. In addition to not encapsulating
FOCAXUAE, the other formulations were not capable of maintaining their gel structure in the
SGF media, purporting that the necessary conditions to sustain such gelation were not met. The
cation concentration in either the SGF or the SIF media were not in concentrations great enough
to elicit an ionotropic gelation mechanism with the LMP. However, one must consider the that
de-esterified LMP is unable to form gels without the presence of calcium. Therefore, no
sufficient gel structures were formed at a low pH. With an increase in the pH (pH 6.8), which
decreases the amount of a divalent cations (Ca+) needed for gelation, gelling was observed in
SIF, which contained calcium chloride. LMP is deesterified in alkaline environments, thus
decreasing the requirement of a divalent cation for gelation (Garnier, Axelos, & Thibault, 1993).
The results of this study showed that, potentially, the delivery system that was designed and
developed using HMP or LMP, gelatin, and HPMC can be used for the controlled release of
flaxseed oil containing astaxanthin.
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CHAPTER 4
4.1

ASTAXANTHIN: CHEMOTHERAPEUTIC PROPERTIES

Introduction
The dietary intake of carotenoids derived from the marine environments provide numerous

health beneficial effects such as antioxidant, antimicrobial, anti-inflammatory, and anti-cancer
activities (Boominathan & Mahesh, 2015). Astaxanthin (AX), a ketocarotenoid, found
throughout marine organisms, most notably particular interest to the crustacean species of
Louisiana (shrimp, Litopenaeus spp. and red swamp crawfish, Procambarus clarkii). Beneficial
properties of astaxanthin include; reducing the risk of heart disease, inflammation, and oxidative
stress, in addition to a plethora of anti-cancer roles (Kowshik et al., 2014; Kurihara, Koda,
Asami, Kiso, & Tanaka, 2002; Palozza et al., 2009; L. Zhang & Wang, 2015). The consumption
of dietary carotenoids is reported to contribute to the inverse relationship between dietary intake
and the risk of major clinical diseases, such as cancer.
Cancer has a global impact on people of all social classes. Breast cancer, the primary cause
of cancer deaths in women, can be classified into estrogen receptors (ERs) +, human epithelial
growth factor receptor 2 (HER2) +, and triple-negative breast cancer (TNBC) subtypes (Qu et
al., 2014; T. Yoshida et al., 2014). Treatment of TNBC is the toughest obstacle for researchers
because of its invasive and aggressive nature, as well there be fewer targeted medications. This
metastatic characteristic of TNBC is the reason for it having the lowest survival rate of any other
subtype of breast cancer. Very few drugs have been approved for the treatment of TNBC.
Treatments for metastatic TNBC are centered around improving the quality of life through
reduction of the cancer-related symptoms, as opposed to providing a cure, the primary goal of
treatment for patients with localized breast cancers (Zeichner, Terawaki, & Gogineni, 2016).
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Over the past years, carotenoids have been delivered to cells in culture incorporated in
liposomes, water-miscible beadlets or mixed micelles (O'Sullivan, Woods, & O'Brien, 2004).
Additionally, organic solvents have been used as delivery vehicles for carotenoids, despite
classic difficulties of insolubility, instability, and cytotoxicity being related to solvent use.
In this study, the effect of ultrasound assisted extracted astaxanthin in flaxseed oil
(FOCAXUAE) from crawfish processing byproducts (CB) delivered to cells in culture on cell
density and the cell propensity of MDA-MB-231 cells, a triple-negative breast cancer cell line, to
undergo an epithelial-mesenchymal transition (EMT), was investigated.
4.2

Materials & Methods

4.2.1

Emulsions with and without astaxanthin preparation for cell treatment
Astaxanthin was extracted by the method described above in section 2.2.3.2. of Chapter 2,

with some modification. Ethanol (200 g) used for extraction of CB (25 g). Three hundred grams
of ethanol was used to extract astaxanthin from a total of 100 g of CB; this includes washing and
filtration procedures. Astaxanthin content in the ethanol extracts was determined based on the
equation adopted from (Takeungwongtrakul & Benjakul, 2016). For determination of astaxanthin
content, 5 g of FO was added to a 100 ml aliquot of the ethanol with astaxanthin extract.
Four amphiphilic surfactants, tween 20 (T20), tween 80 (T80), triton X (TX), and
sunflower lecithin (SL), were used to emulsify the oil-in-water (flaxseed oil in DMEM)
formulations to deliver astaxanthin extracted CB in vitro. Surfactant was mixed with DMEM to
prepare a 1:100, 1:1000 or 0.5:1000 dilutions. The mixtures were sonicated for 60 s using an
ultrasonic processor (Model CPX 500, Cole Palmer Instruments, Vernon Hills, IL, USA) with a
2mm stepped microtip probe threaded to the 10 mm probe of an ultrasonic booster horn fitted to
an ultrasound converter for producing sonic waves at a frequency of 20 kHz electrical energy.
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Following surfactant selection, emulsions were prepared by adding oil (100mg, 10%w/v) to
1mL of DMEM. Then 25 mg of emulsifier were added (2.5% w/v). Then, the solution was
vortexed at 3000 rpm for 1 min before further emulsification using an ultrasonic processor
(Model CPX 500, Cole Palmer Instruments, Vernon Hills, IL, USA) with a 2mm stepped
microtip probe. This microtip probe was threaded to a 10mm horn fitted on an ultrasonic
converter, for producing sonic waves at a frequency of 20 kHz. Emulsions were prepared in a 5
ml amber Eppendorf to prevent photooxidation.
4.2.2 Emulsion Stability
Emulsions prepared by adding oil (100mg, 10%w/v) to 1mL of DMEM, then adding 25 mg
of emulsifier (2.5% w/v). This solution was vortexed at 3000 rpm for 1 min before further
emulsification using an ultrasonic processor (Model CPX 500, Cole Palmer Instruments, Vernon
Hills, IL, USA) with 13 mm probe connected to an ultrasound converter for producing sonic
waves at 20% power of 20 kHz electrical energy. Similar to the parameters used for preparing
emulsions for treatments. To measure turbidity at 500 nm 10ul of emulsion was added to 3 mL of
0.1% sodium dodecyl sulfate (SDS, a 300-dilution factor) in cuvettes immediately after emulsion
preparation. Other data not shown.
Following surfactant selection, emulsions were prepared by adding oil (100mg, 10%w/v) to
1mL of DMEM. Then 25 mg of emulsifier were added (2.5% w/v). Then, the solution was
vortexed at 3000 rpm for 1 min before further emulsification using an ultrasonic processor
(Model CPX 500, Cole Palmer Instruments, Vernon Hills, IL, USA) with a 2mm stepped
microtip probe. This microtip probe was threaded to a 10mm horn fitted on an ultrasonic
converter, for producing sonic waves at a frequency of 20 kHz. Emulsion were prepared in a 5
ml amber Eppendorf to prevent photooxidation.
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4.2.2

Cell culture
The human breast cancer cell, MDA-MB-231 (passages 30–32) was cultivated in 100-mm-

diameter tissue culture flask. Cells were maintained in 5% CO2 at 37⁰C and cultured in
Dulbecco’s modified Eagle’s medium (DMEM; Gibco BRL, Grant Island, NY) supplemented
with 10% Hyclone Cosmic Calf Serum (HyClone Laboratories, Utah), 50 ng/mL insulin (SigmaAldrich, St. Louis, MO, USA), and 1% MEMAA, NEAA, sodium pyruvate and antibioticantimycotic (Gibco, Dublin, Ireland). For experiments, MDA-MB-231 cells were seeded at a low
density (5 × 103 cells/well) into a 96-well plate.
4.2.3

MDA-MB-231 cell density
To examine the anticancer effects of astaxanthin emulsions (AXE, 3µM, 5µM, and 7µM)

on MDA-MB-231 cells, a 96-well plate was incubated for 2 days, before being treated.
Following incubation period, AXE was carefully removed from wells containing cells. Cells
were stained with 33% crystal violet, 20 µL per well, for 15 minutes on a rocker then washed
and allowed to dry (2 hours). After drying, cells were either assessed for morphological
characteristics or stains eluted for relative cell viability (RCV) per section 4.2.3. The cells were
imaged using an inverted fluorescence microscope (Nikon Eclipse Ti2), and NIS Elements
Advanced Research Microscope Imaging Software (NIS Elements AR, Nikon).
4.2.4 In vitro assessment of astaxanthin exposure from AX emulsions on MDA-MB-231
cells for cell viability
The viability of the MDA-MB-231 and cellular contact with AXE was evaluated using
absorbance measurements. The absorbance indicated relative cell viability (RCV) in regards to
the relative number of total cells (fixed cells with uncompromised membranes to retain the
crystal violet dye) in a one well compared to another. The emulsions diluted with DMEM was
carefully removed from cell monolayers, then stained with crystal violet was added to the wells
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containing cell monolayers and placed on a rocker for 15 minutes. Subsequently, the plates were
rinsed of the stain with water and allowed to dry (2 hrs) RCV was evaluated numerically by
measuring the optical density (absorbance at 570 nm) with the cell imaging multi-mode plate
reader Cytation™ 5 (Biotek, Winooski, VT). RCV was calculated based on the equation 4.1:
-'$NM#*' ('$$ *#NO#$#M+ =
4.2.5

(C<2:C42 78 6:2C62= 1299A CtA7:tCB;2ut9CBv)
(C<2:C42 78 ;7B6:79 1299A CtA7:tCB;2ut9CBv)

× 100

(Eq. 4.1)

Statistical Analysis
All data were analyzed with GraphPad Prism 4.0 software (GraphPad Software, Inc.; San

Diego, CA, USA). The RCV was evaluated by one sample t-test and Wilcoxon test at a
significance level of 0.05 and plotted by GraphPad Prism.
4.3

Results & Discussion
The genomic characteristics and nature of TNBC cells make them difficult to target and

treat. The utilization of a natural anti-cancer agent, like astaxanthin, is important for improving
upon the adjuvant treatments available for TNBC patients. This not only reduces the side effects
of systemic therapies routinely used, it also improves upon the quality of life during recovery.
Over the past years, carotenoids have been delivered to cells in culture incorporated in
liposomes, water-miscible beadlets or mixed micelles (O'Sullivan et al., 2004). Additionally,
organic solvents have been used as delivery vehicles for carotenoids, despite classic difficulties
of insolubility, instability, and cytotoxicity being related to solvent use.
During preliminary tests, a visual confluency estimate was used to assess the effects of the
four surfactants to emulsify DMEM and flaxseed oil on the viability MDA-MB-231 cells.
Multiple variations in the concentration of surfactants (i.e., high, medium, and low) SL, T20,
T80, and TX were assessed. Sunflower lecithin (SL) was found to show minimal deleterious
effects on the viability of MDA-MB-231 cells, as seen in Figure 4.1. Various concentrations
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were tested to determine the ideal amount of surfactant to achieve the optimal response from the
MDA-MB-231 cells as it relates to viability. Visually inspections show that T20 and TX have a
greater anti-proliferative or apoptotic effect in terms of cell density than do T80 and LC on
MDA-MB-231 cells. Some results not pictured.
SL:FO

T20:FO

T80:FO

TX:FO

Low

Medium

High

DMEM

Figure 4.1. Visual confluency estimation to surfactant and optimization. Microscopy using
a Nikon Eclipse Ti2 inverted fluorescence microscope at 2x magnification.
Once the dosages optimize with a suitable concentration of surfactant to use in delivering
AX in vitro, a closer assessment of the effects of surfactant/emulsifier on the relative cell number
(%, RCV) of MDA-MB-231 cells was assessed before proceeding with treatments. Sunflower
lecithin showed a more representative RCV (79.37±0.87) than the other surfactants, (T20
(8.6±2.51), T80 (25.04±3.00), and TX (17.11±3.00)), shown in Figure 4.2. Also, considering the
ultimate goal of the study is to utilize natural rather than synthetic compounds to attenuate the
deleterious effects of TNBC and the adjuvant therapies available.
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0
DMEM SL T20 T80 TX
Figure 4.2. MDA-MB-231 % cell viability in different surfactants. Means±SEM of
triplicate determinations. **p<0.01, ***p<0.001. DMEM = Dulbecco’s modified Eagle’s
medium. SL = lecithin. T20 = Tween 20. T80 = Tween 80. TX = Triton X.

AX emulsions (AXE) were prepared in DMEM with 10% sunflower lecithin (SL) at
concentrations of 0.0025:0.005% to 0.1:0.2% (LD:AXE, wt:wt). Controls prepared at same
concentrations as LD:AXE, using flaxseed oil without AX. MDA-MB-231 cell line was seeded
at 5 × 103 cells/well in 96-well plates and incubated at 37 °C for 24 hours. Cells were then
treated with 100 µL/well LD:E or LD:AXE. LD:AXE treated cells (image b, 1-9) displayed a
mesenchymal-to-epithelial transition (MET) compared to control treated cells (image a, C and
E), which suggests a less metastatic and aggressive phenotype. LD:AXE treatments resulted in a
decrease in cell number in a somewhat dose-dependent (3 µM, 5 µM, and 7 µM AX) manner,
seen by RCV decreasing by 46.31%, 42.2%, and 55.51%, respectively, from the normalized
value (Figure 4.3).
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Figure 4.3. MDA-MB-231 viability of treated cells. Means ± SEM of triplicate
determinations. **p<0.01, ***p<0.001. LC = lecithin control. 3 µM = LC with 3 µM
astaxanthin. 3 µM = LC with 5 µM astaxanthin. 3 µM = LC with 7 µM astaxanthin.

The morphology of astaxanthin treated cells compared to untreated cells showed a
decreased number of cells resembling a mesenchymal-like phenotype (Figure 4.4. b) 1-9). This is
suggestive of a mesenchymal-to-epithelial transition (MET), or reversal of EMT. EMT has been
reported to be the cause of the invasive, metastatic, and multi-drug resistant nature of cancer
cells (Chaffer, San Juan, Lim, & Weinberg, 2016; Du & Shim, 2016; Little et al., 2016; Milano,
Muthuswamy, & Asthagiri, 2016; Pastushenko & Blanpain, 2019). In this study, LC:FO alone
did not significantly affect MDA-MB-231 cell viability or MET. Thus, indicating the possibility
that neither LC or FO possess any cytotoxic or genotoxic activity in the levels used.
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Figure 4.4. Evaluation of astaxanthin on the morphology of MDA-MB-231 triple-negative
breast cancer cell line in vitro by darkfield microscopy. Microscopy using a Nikon Eclipse Ti2
inverted fluorescence microscope.
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Microscopy revealed (Figure 4.4) MDA-MB-231 cells displayed (A) epithelial and (B)
mesenchymal-like, spindle-shaped cells. (C, E) Control MDA-MB-231 cells in DMEM and (D,
F) treated MDA-MB-231 cells by brightfield microscopy. MDA-MB-231 cells grew as sheet-like
monolayers (indicated by arrow) of tightly packed colonies. (Image b) MDA-MB-231 cells in
flaxseed oil DMEM emulsion with astaxanthin (AX) increasing in concentration appears to
increase cell to cell interactions (4-9), compared to the loss of cell to cell interaction at 7 µM
treatments (1-3). MDA-MB-231 cells treated with AX at 3µM, 5µM, and 7µM concentrations
exhibit a reduction in cells displaying mesenchymal-like morphology. MDA-MB-231 cells
treated with 5 µM astaxanthin had an increase in cell population (4), compared to those treated
with 7 µM (1-3) having small rounded cells with a globular appearance (possibly dead with
debris). Numerous MDA-MB-231 cells are egg-shaped and flattened with characteristic
morphologies resembling epithelial cells. Some cells show filopodia (8). Different concentrations
of AX exert varying degrees of cell to cell adhesion (4,7) and dissemination (1). More
importantly, spindle-like cells with mesenchymal morphology appear to be reduced in a dose
dependent manner.
In addition to cells gaining motility and invasiveness when they undergo an EMT, they also
develop novel interactions with the microenvironment. Such interactions lead to the migration of
cancer cells from one site to the next.
4.4 Conclusion
The studies reported here demonstrate that AX exerts anticancer effects on MDA-MB-231
cells in vitro with respect to cell viability and morphology. The RCV of MDA-MB-231 was
reduced. It can be seen that the incorporation of SL as a vehicle for administration of the
bioactive compound AX, has a significant effect on the growth or phenotypic changes to MDA-
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MB-231 cells based on the RCV (Figure 4.3). The same can be said about flaxseed oil.
Additionally, MET was suggested to be induced in vitro, thereby decreasing the TNBC
metastasis and possibly prolonging survival. However, an in vivo analysis would have to be
performed before such correlation can be accepted. These results provide insight on the potential
application of crawfish derived astaxanthin, as a potential therapeutic agent in TNBC treatment.
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CHAPTER 5

CONCLUSION

Astaxanthin (AX) was extracted from crustacean processing byproducts, shrimp
processing byproducts (SB) and crawfish processing byproducts (CB), using flaxseed oil. Higher
extraction yields of AX is achieved using CB. Extraction of AX from CB in a continuous
ultrasound assisted extraction (UAE) system yielded even greater recoveries than UAE of AX
from SB and the conventional extraction method from SB and CB. Effects of conventional
extraction and UAE of AX from SB and CB on the oxidation and stability of the flaxseed oil
were evaluated. The UAE of AX extracted from CB had a greater antioxidant capacity, than
other extracts tested. UAE was effective for increasing the recovery of AX from CB and
preventing a loss in the quality of the flaxseed oil used as an extraction solvent. The UAE
method was also effective for concentrating AX to be used in the design and development of a
delivery system. The delivery system, composed of three polymers, hydroxypropyl
methylcellulose (HPMC), gelatin (G), and pectin (P), was used to encapsulate flaxseed oil
containing AX (FOAX). The polymeric delivery system was capable of delaying the release of
the FOAX extracted CB in simulated gastrointestinal tract fluids by several mechanisms afforded
by the polymers (HPMC as an enteric coating, G gelling properties to slow release, and P gelling
properties in ionic solutions to slow release). Additionally, AX extracted from CB showed
anticancer properties against a triple negative breast cancer (TNBC), MDA-MB-231 cells in
vitro. Exposure of the MDA-MB-231 cells to AX altered cell morphology. A greater number of
cells exposed to AX reversed their epithelial-to-mesenchymal transition (EMT), representing a
less aggressive phenotype of TNBC MDA-MB-231. Nonetheless, an in vivo analysis needs to be
performed prior to a correlation between a mesenchymal-to-epithelial transition (MET) and
decreased metastasis with increased life expectancy in human subjects.
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